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ABSTRACT 
The wide-spread use of organophosphate (OP) pesticides 
has been found to improve the agricultural out-put, besides 
controlling the vectors cf several parasitic diseases, such 
as malaria, filaria, etc. OP pesticides are preferred among 
other pesticides due to their rapid biodegradability. 
However, indiscriminate and ever-increasing application of OP 
pesticides has been reported to induce various toxicities to 
man and other non-target organisms. Brain is the most 
susceptible and vulnerable organ of the body, and hence 
attacking the nervous systeu-. is the easiest and surest way of 
chemically upsetting the body metabolism. Generally, most of 
the organophosphates are referred to as 'anticholinesterases' 
as they inhibit the acetylcholinesterase (AChE), resulting in 
the accumulation of acetylcholi ne (ACh) at the synapses, and 
thereby leading to disruption of nerve function. ACh 
accumulation also stimulates cholinergic excitation which,,in 
turn, may deplete the monoamine neurotransmitters. Monoamine 
oxidase (MAO) is the man enzyme which degrades the 
monoamines. Changes in the amine concentrations have been 
found to produce various behavioural dysfunctions. Brain is 
one of the most lipid-..ich regions of the body. Lipid 
peroxidation is an imports. lipid-chain degradation process. 
Nucleic acids and proteins £i:e also important constituents of 
brain. Sulfhydryl groups and enzymes glutathione-S-
transferase (GST) and superoxide dismutase (SOD) are related 
to the detoxification process against the toxicants, e.g. 
organophosphates. 
The present study embodies neurotoxic effects of 
diinecron, a potent and widely used organophosphate, on AChE, 
monoamines, MAO, open field behaviour, lipid metabolism, 
lipid peroxidation, sulfhydryl groups, GST, SOD, nucleic 
acids and protein contents of albino rats . Efforts were also 
undertaken to detect the dimecron fractions from the CNS 
regions of intoxicated rats. Also, protective effects of 
antioxidant, acetylhomocysteine thiolactone (cithiolone) on 
the adverse effects of dimecron, were studied. 
Open field behaviour was studied following the method 
described by Ali et al (1980). Enzymes AChE and MAO were 
assayed by the procedures of Ellman et al (1961) and Tabor et 
al (1953), respectively. Monoamines, were determined by the 
method of Welch and Welch (1969). Total lipids, 
phospholipids, cholesterol, gangliosides and sulfhydryl 
groups were estimated by the procedures of Woodman and Price 
(1972), Marinetti et al (1962), Henly (1957), Pollet et al 
(1978) and Sedlak and Lindsay (1968), respectively. Rate of 
lipid peroxidation was determined by the procedure of Utley 
et al (1967). Activities .^f GST and SOD were studied by the 
methods of Habig et al (1974) and Marklund and Marklund 
(1974), respectively. Nucleic acids DNA and RNA were 
estimated following the methods of Burton (1956) and Dische 
II 
(1955), respectively, while the total proteins were 
determined by the procedure of Lowry et al (1951). Contents 
of dimecron were detected from the CNS by thin-layer 
chromatography followed by spectrophotometric method of 
Anliker and Menzer (1963), modified by Naqvi and Hasan 
(1990). Significant findings of the present study are 
summarized as follows: 
[A]. Dimecron intoxication (2.0 mg / Kg b. wt, ip) for seven 
days, was found to produce the undermentioned results: 
- A gradual daily decrease was observed in the open-field 
behaviour parameters, i.e. ambulation, rearing and 
preening. The greatest decrement was noticed on the 
seventh day of injection. 
- The activity of AChE was inhibited significantly in all 
the regions of the CNS, viz. cerebrum, cerebellum, brain 
stem and spinal cord. Maximum depletion was found in the 
spinal cord. 
Levels of monoamines viz. dopamine (DA), norepinephrine 
(NE) and serotonin (5-HT) were found to be depleted 
significantly in all the CNS regions. Maximum decrement 
of DA was noticed in the cerebellum, while NE and 5-HT 
were maximally decreased in brain stem and cerebrum, 
respectively. 
Ill 
significant elevation was observed in the MAO activity of 
all the CNS regions. Cerebellum showed maximum increment 
while minimum increase was noticed in the brain stem. 
Lipid contents were found to diminish in various CNS 
regions. Total lipids and phospholipids decreased in all 
the regions of the CNS with maximum depletion being 
noticed in cerebrum. Cholesterol was found to deplete in 
cerebrum, cerebellum and spinal cord. Maximum decrement 
of cholesterol was however, detected in the cerebrum. 
Significant diminution in the level of gangliosides 
was observed in cerebrum, cerebellum and brain stem. 
Rate of lipid peroxidation enhanced considerably in 
various region of the CNS. 
Content of total, non-protein bound (NPB) and protein-
bound sulfhydryl groups were found to decrease 
significantly in different CNS regions. Spinal cord showed 
maximum decrement of total and NPB sulfhydryl (-SH) groups 
while protein-bound -SE groups depleted most significantly 
in the cerebrum. 
Significant inhibition of GST activity was observed in all 
the CNS regions. Spinal cord revealed maximum GST 
inhibition. 
IV 
- Activity of SOD also depleted in alia the regions of the 
CNS with maxiinum depletion occurring in spinal cord. 
The concentration of DNA was found to decreased 
considerably in all the CNS regions. Maximum decrement was 
detected in the cerebrum. 
Levels of RNA increased in cerebrum, cerebellum, brain 
stem and spinal cord with the maximum increment 
discernible in the spinal cord. 
Protein levels were found diminished in all the CNS 
regions. Most significant diminution of proteins was noted 
in the cerebrum. 
[B] When acetylhomocysteine thiolactone (cithiolone) was 
administered (8.0 mg/Kg b. wt, ip) simultaneously with 
dimecron, remarkable protection was observed against the 
dimecron-induced adverse effects on open field behaviour, 
AChE, MAO, lipid peroxidation, and GST and SOD activities 
in all the regions of the CNS. 
[C] Dimecron was recovered from various CNS regions of the 
rats intoxicated with three graded doses of dimecron (1.0, 
1.5 and 2.0 mg /Kg b. wt, ip x 7 days). A remarkable dose-
related elevation was observed in the concentration of 
dimecron accumulated in cerebrum, cerebellum, brain stem and 
spinal cord. Cerebrum showed maximum percent recovery 
compared to the concentration of dose injected. 
V 
It can be concluded from the present study that 
dimecron intoxication adversely perturbs the open field 
behaviours and induces alterations in the neurochemical 
metabolism, specially ACh, monoamines, lipids, nucleic acids, 
proteins and related enzymes. Also, antioxidant cithiolone 
protects against the dimecron neurotoxicity. Moreover, the 
accumulation of the dimecron in the CNS regions, reported for 
the first time, supports the view of earlier workers that 
organophosphates probably induce neurotoxicity by readily 
penetrating the blood-brain barrier. 
VI 
1. INTRODUCTION 
One of the most important and concerning problems faced 
by the humanity is that of population explosion. Providing 
food to ever increasing millions of mouths all over the globe 
has become a hard nut to crack. Besides, man has also to 
combat the menace of pests which not only destroy the crop, 
but act as vectors of some deadly parasitic diseases, e.g. 
malaria, filaria, etc. 
Crop protection by means of chemicals has become 
increasingly an object for public discussion ever since 
Rachal Carson published her book "Silent Spring". According 
to the understanding of the basic concepts involved in this 
difficult scientific field, two lines of argument follow 
which tend to be ideological or of a more objective nature. 
One may regard chemical crop protection simply as a profit-
induced poisoning of the environment or one can try to 
analyse the various factors that have compelled us to use 
chemical agents in the food production. The deciding factor 
is, of course, the develcj. of world population. 
During the last fo. / five years, there has been a vast 
increase in variety and joiisumption of pesticides used in 
order to improve agricultural yields and preserve harvested 
crops. The use of pesticides is steadily increasing so much 
so that the requirement for 1975-76 was twice as that of 
1971-72, and in 1983-84 it increased two and half folds. 
The word "pest" includes widely divergent group of 
organisms e.g. insects, rodents, weeds, fungi, molluscs etc. 
'Pesticides", therefor,, comprise of a large variety of 
compounds of diverse cht-;nical nature and biological activity 
grouped together, only on the basis that they are used to 
destroy or eliminate pests. Some of the classifications are 
based on (a) the class of pest against which they are used, 
(b) source from which they are obtained (c) based on 
combination of biological activity and chemical structure. 
The last mentioned is the most commonly used criterion of 
pesticide classification, and the pesticides may be 
classified as Insecticides, Weedicides, Rodenticides, 
Fungicides, Fumigants, Acaricides, Nematocides and 
Molluscicides (Table 1.1). 
Pesticides are used (a) in agriculture for protection 
of crops, (b) in public health programmes, against the 
control of disease vtCLors e.g. malaria, typhus, yellow 
fever, filaria, etc., (c) for protection of material, 
incorporation in paints, timber, etc. (d) in industry, for 
the control of hazardous vegetation in forests, airports, 
factory sites, and fumigation of ships etc. (e) domestic use 
as household and garden spray and control of ecto-parasites 
in pet animals, and (f) as an application to clothings skin 
and for the control of ecto-parasites e.g. fleas, lice, 
mites, etc. 
Pesticides are only effective if they are toxic to some 
forms of life. As a number of pesticides are proved 
TABLE 1.1 
CLASSIFICATION OF PESTICIDES 
Pesticides Examples 
(A) Insecticides: 
i) Organophosphate 
ii) Organochlorine 
iii) Organochlorine 
iv) Botanical 
(B) Weedicides: 
(C) Rodenticides: 
(D) Fungicides: 
(E) Fumigants: 
(F) Acaricides: 
(G) Nematocides: 
(H) Molluscicides: 
Phosphamidon, Dichlorvos, Methyl 
parathion, Metasystox, TEPP 
DDT, Endosulfan, BHC, Aldrin, 
Chlordane 
Carbaryl 
Pyrethrine, Nicotine 
Paraquat, Dalapon, Nitrofen 
Ammonium sulphate 
Zinc phosphate. Warfarin 
Copper sulphate. Copper 
oxychloride. Sulfur dust, 
Dicofol, Ethion 
Alluminium phosphate 
Metham-sodium, Fensulfothion 
Metaldehyde 
indubitably poisonous lo people exposed to them, there is a 
natural concern that their extensive use in food production 
could result in a health hazard to those who ultimately 
consume food which at some stage has been exposed to one or 
more pesticides. Pesticides have been shown to affect 
adversely a number of biological functions such as nervous 
system in many organisms, reproduction in birds and fish, 
hormonal balance in mice, the temperature regulating 
mechanism in fish, liver functions in man, etc. (Gupta 1975). 
1.1.0 Organophosphates: 
Organophosphate (OP) compounds are widely used as 
potent contact and systemic pesticides in agriculture, 
household and public health programmes. The consumption of 
organophosphate pesticides has sharply increased in recent 
years. A majority of organophosphate pesticides in use are 
basically of a single chemical nature and are the derivatives 
of phosphoric acid. They are preferred among other pesticides 
due to their rapid biodegradability as well as penetrant and 
volatile properties (Moriarty 1975). Besides improving the 
crop production, some organophosphates have also proved 
helpful in controlling vectors of certain deadly diseases, 
such as malaria, filaria, leishmaniasis (Casida and Baron 
1976). 
The use of organo^^hosphates as agricultural chemicals 
is not restricted to insecticides. Some of the 
organophosphates also serve as acaricides, fungicides, 
anthelmintics, nematocides, cotton defoliants and crabgrass 
control agents (Casida 1964) . Some OP compounds have also 
been used medically for treatment of diseases such as 
myasthenia gravis and glaucoma. But because of narrow gap 
between therapeutic and toxic doses, this use is not 
recommended. Unfortunately, during World War II, a group of 
most toxic OP compounds, "nerve gases" (Soman, Sarin, Tabun) 
were successively used by Germans as chemical weapons. 
Generally, most of the organophosphates are frequently 
referred to as "esterase inhibitors" or "anticholinesterases" 
since they inhibit carboxylic esterase enzyme, 
acetylcholinesterase (AChE) resulting in the accumulation of 
acetylcholine (ACh) at the synapses, and hence lead to 
disruption of nerve function (Johnson 1976). Indiscriminate 
and ever-increasing consumption of OP pesticides has led to 
severe health hazard to man and other non-target organisms. 
Numerous incidents of OP poisoning have been reported all 
over the world. Statistics for 1969 Indicate that 50-80% of 
poisons detected in medicolegal cases in Punjab (India) 
belonged to organophosphate and organochlorine compounds 
(Bami 1971). Moreover, Tabershaw and Cooper (1966) observed 
that acute OP toxicosis degrades axons due to the 
interference of organophosphates in the regular metabolism of 
nerve cell bodies. Recently, Naqvi and Hasan (1990) have 
reported dose-related accumulation of organophosphate 
pesticide, dimecron, in various regions of the central 
nervous system, which suggests that organophosphates cross 
the blood-brain barrier. 
From our laboratory, a number of studies have revealed 
various neurobiochemical alterations following exposure to 
organophosphates, dlchlovos (Ali and Hasan 1977, Vadhva & 
Hasan 1986), metasystox (Tayyaba & Hasan 1985) and methyl 
parathion (Hasan & Khan 1985, Khan and Hasan 1988). 
1.1.1 Historical Overview: 
Since the dawn of the civilization, man has been 
fighting a never-ending battle against the army of pests. 
Search for powerful pest controlling chemicals led to 
extensive studies all over the world. 
Barely 170 years ago, Lassaign (1820) reacted alcohol 
with phosphoric acid in a reaction analogous to that with 
sulphuric acid and therewith launched the chemistry of 
organophosphorus compounds. It was followed by a number of 
studies with an aim to prepare organophosphate compounds 
possessing insecticidal properties. 
In 1854, Clermont synthesized tetraethyl pyrophosphate 
(TEPP) by alkylating the silver salt of pyrophosphoric acid 
with alkyl halides (Clermont method). Clermont (1854), 
however, did not recognize the important physiological 
activity of this compound. TEPP was later found to be a 
potent, anticholinesterase pesticide (Casida 1964). 
0 \ Hs 
C2 H5 0 0 OC2H5 
This ester, which may be regarded as a link between 
inorganic and organic chemistry, was often described in the 
following decades and yet almost 80 years were to pass before 
its insecticidal properties were discovered. 
C.A.A. Michaelis (1894-1913) in Germany and A.E. 
Arbusov (1906-1964) in Russia can be named as the founders of 
classical phosphoric ester chemistry. 
In 1897 Michaelis Becker reacted sodium dialkyl 
phosphite with ethyl iodide according to the following 
scheme: 
• 11,0 H-P, 
0 
Pb 
" O C 2 H 5 OC2H5 2 5 
(I) (II) 
The reaction of sodium salts of dialkyl phosphites (I) 
with alkyl halides became known as the Michaelis-Becker 
reaction and the compound so obtained, a phosphonic ester 
(II) was not identical with the phosphorous acid ester (III). 
OC2H5 
.^OCjHs 
OC2H5 
which they synthesized from phosphorus trichloride and sodium 
ethylate. In 1898, Michaelis and Kaehine isolated a compound 
from trialkyl phosphite and methyl iodide, whose structure 
they did not recognize as being analogous to (II) . The 
problem was taken up again seven years later by Arbusov in 
1906 who repeated the reaction of phosphorus trichloride with 
sodium ethylate. He succeeded in reacting a highly purified 
triethyl phosphite (III) with ethyl iodide at room 
temperature by the following method: 
CoHcO 
2 5 . C2H5X 
C2H50^P • > 
C2H5O 
A ? C2H50^P-C2H5 
C2H5O 
e 
x 
C,HcO // 
>P ^ X 
C2H5O H C2 H5 
III SCHEME 2 ( ARBUSOV REACTION ) 
Scheme 2 (Arbusov Reaction) 
In 1903, Michaelis synthesized phosphorus-nitrogen 
compounds from phosphorus trichloride, pentachloride, 
phosphorylchloride, thiophosphorylchloride and ammonia or 
amines. In the reaction of phosphorus trichloride with alkyl 
amines he obtained N-alkyl amino-dichlorophosphine (V), which 
he oxidized with chlorine to the tetrachlorides (VI). 
0 
V ) ( V I ) ( V I I I 
CI2 H7O7 u 
R2 N - PCI3 i — > R^ N — P C l ^ - ^ R j N - P < 
Atmospheric moisture sufficed to hydrolyse these 
tetrachlorides to dialkylaminophosphorodichloridates (VII). 
Also, in the reaction of phosphoryl chloride with aliphatic 
amines, he found R2NPOCI2 (VII) in addition to 
phosphorodiamidochloridate (VIII), an important starting 
material for phosphorylation reaction. 
In 1917, Balareff published several papers concerning 
the action of phosphoryl chloride on methyl and ethyl alcohol 
but the final structure of pyrophosphoric acid was not 
clarified until 1930 by Nylen who established the symmetric 
form. He synthesized the tetra-alkyl pyrophosphate and mixed 
pyroesters. 
In 1932, Lange and Krueger, working in Berlin, prepared 
the esters of monofluorophosphoric acid from its silver salts 
with alkyl iodide. They were the first to draw attention to 
the highly toxic properties of these compounds, including 
respiratory distress, clouding of consciousness, temporary 
blindness and photophobia. Biological and chemical studies on 
organophosphate toxicants during the following decade were 
largely restricted to German laboratories, Schrader (1935-
1970) been working on acid fluorides in search for compounds 
with ascaricidal and aphicidal activity. In this field he was 
first successful with the methane sulfonyl fluoride (CH3 SO2 
F) in 1946, which is still used today in special cases as a 
fumigant. By changing from sulfuric acid to phosphoric acid 
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he was led to what became later his main work. As starting 
material he used N, N - dimethyl phosphoroamidodichloridate 
(IX) which is easily convertible to difluoride. 
( C H , ) , N - P - C U 2 K F > { C H , ) , N - P - F • 2 K C I 
3 2 \ 3 2 \ 
CI F 
( I X ) 
At first he found only weak insecticidal properties 
until he reacted the dichloride with potassium cyanide 
(Schrader 1937 and 1952), which resulted in the highly toxic 
and miotic Tabun (X) (Schrader and Gebhardt 1939 and 1953). 
(CH3)2 N - P ^ C l • 2KCN > ( C H 3 ) 2 N - P ^ C N •2KCN {CH3)2N-P^CN 
CI CN OC2H5 
Then he replaced the dialkylamino group by an alkyl 
group (Collomp 1949) and so arrived, in 1937, at the 
pysiologically extremely potent compound, Sarin (XI). Soman 
(XII), however, did not originate from Schrader, but was 
synthesized in 1944 in Heidelberg by commission of the 
"Heereswaffenamt" (Riser 1950). Due to their high mammalian 
toxicity, neither Sarin nor Soman were used as insecticides 
(Lohs 1967). 
H3C 0 
P v . p. 
H3C ( X I ) H3C , x „ , 
During World War II, Tabun, Sarin and Soman, 
collectively known as "nerve gases" were successfully used by 
Germans as potential cheinical warfare. 
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Dimethyl phosphoroamidodichloridate served Schrader 
(1946) as the key substance for the synthesis of octamethyl 
pyrophosphoro- amidate (XII), which is a potent systemic 
insecticide. 
In honour of Schrader, scientists of Pest Control Ltd., 
in 1950 named OMPA as "Schradan". 
(CH3) N^ //0 0./N(CH3)2 J ^  > p p 
By reacting phosphoryl chloride with triethyl 
phosphate, a reaction which has become known as "Schrader 
process", Schrader (1939/1943) synthesized tetraethyl 
pyrophosphate (TEPP). 
In 1941, Adrian, Felberg, Kilby (1947), and Wirth 
(1949) discovered the cholinesterase inhibiting action of the 
organophosphates. This was occasioned by an attempt to 
clarify the miotic action of DFP (XIV). 
I — CHjH^O "^ F 
(XIV) 
In 1952-54 W. Perkow (Perkow et al 1952; Perkow 1954) 
described the common reaction of -halogen carbonyl compounds 
with triethyl phosphite and was the first to formulate 
correctly the end products as dialkylvinyl phosphates (XV). 
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The reaction in the following equation has, therefore, 
become known as the Perkow reaction: 
RO f S .RX RO, R 
RO^P^RrC-C-R, 
/ ' I J I 
RO ' ( X V ) 1 
Historically, the enol phosphates were discovered by 
several teams of researchers at almost the same time. In the 
first papers, the structure was presumed to be an 
ketophosphonate, probably under the influence of the results 
published by Arbusov et al. 
Mattson et al (1955) reported the occurrence of 
dichlorvos (DDVP) as a by-product of dipterex (trichlorfon). 
Rosin and Haus (1956/59) claimed a new process for the 
synthesis of trichlo f oii and described the alkaline 
rearrangement of trichJorfon to dichlorvos. 
, /OH ROs^^^O 
PC13*3R-CHK > 
OR RO C H - R ' 
OH 
A different route was discovered by Lorenz (1954/57) 
who showed that trichlorfon (XVI) is hydrolysed to dichlorvos 
(XVII). 
HC, H3CO C H - C C I 3 - ^ l i ^ i i > C H 3 0 / ' ^ ' ^ 0 - C H = C C l 2 
( X V I ) • ( X V I I ) 
Phosphamidon (XVJTI), a member of the class of enol 
phosphates or vinyl phosphates, was first prepared by E. 
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Beriger in 1955 by condensing -halocarbonyl compounds with 
trialkyl phosptites, according to the Perkow reaction 
CH3O CH3O 0 
CH 0 —P*0 = C-C-C0-N(C,Hc)—>CH CI- /P^ f 
3 / 1 ^ ^ " 0 - C = C - C 0 - N ICNHRH CH3O CH3 CH3O I ^ ^ ^  
CH3 (XVIII) 
It has been estimated that over 50,000 organo-
phosphorus compounds have by now been synthesized and 
screened for their insecticidal potency, of which over 3 
dozen have been produced commercially (Chadwick 1963) . 
1.1.2. General Structure and Nomenclature : 
Schrader proposed a type formula for insecticidal 
organophosphates in 1937; 
where groups Rj and R2 may be alkoxy, alkyl, aryloxy, aryl, 
or substituted amino groups. X contains oxygen or sulphur, 
and the acyl group (Y), is a good leaving group; consisting 
of fluoride, cyanide, pyrophosphate, substituted phenoxy, 
thio-alcohols, aliphatic and heterocyclic enoles etc. 
A simple, logical and generally accepted nomenclature 
of the organophosphorus compounds does not exist. Tradition 
amongst individual teams plays a great role, as is apparent 
from a comparison of the Russian (Arbusov) and German 
(Michaelis) schools. 
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The type I compound resulting from the Arbusov reaction 
RO \ RO 
A p . r Hal ^ >p , RHol 
/ RO ^R-rq , 
(1) 
is designated phosphinic acid ester by some Russian authors. 
In Germany, on the othe: hand, the compound is described as 
phosphonic acid ester, and phosphinic acid derivatives are 
understood to be compounds with two P-C bonds: 
R^ ^OR (II) 
This often resulted in several chemical and trade names 
for each compound. Fortunately, the 1952 agreement between 
England and United States of America on the nomenclature of 
organophosphates is now followed by most of the scientists. 
In this system, esters are named as derivatives of the 
corresponding parent compounds. A 'phosphate' is a derivative 
of phosphoric acid, e. 'phosphonate' a derivative of 
phosphonic acid. Ester-; containing a nitrogen, sulfur or 
halide attached to pho£t..c'i.as have appropriate suffixes. The 
structures of the organophosphate derivative base names have 
been illustrated in Table 1.3. Of these simple derivatives, 
there can be numerous combinations such as phospho-
nothionates, phosphorodiamidofluoridates, vinyl phosphates, 
etc. 
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TABLE 1.2: DERIVATIVE BASE NAMES OP OP COMPOUNDS 
Phosphate (R0)3 P=0 
Phosphonate (R) (RO2) P=0 
Phosphinate (R)2 (RO) P=0 
Phosphor amidate (RNH) (R0)2 P=0 
Phosphorothionate {R0)2 P=0 
PhosphorothiOlate (RS) {R0)2 P =0 
Phosphorofluoridate (F) (RO), R=0 
Once the derivative-base name is established, the R-
substituent groups are included in the name with an 
indication of the atom to which they are attached. The 
structural formulae, chemical names and common names of 
several representative organophosphates are given in Table 
1.3. 
The multiplicity of organophosphates frequently causes 
them to be victims of confusion between common and 
proprietary names. A p;:>prietary name is the one usually 
allocated by the manufacturing company which owns the 
compound. It should always be used with a capital letter, and 
is often followed by (R) to show that it is a registered 
trade mark. 
1.1.3 Structure Activity Relationship (SAR)i 
Repeated referencea have been made to "Schrader's 
rule", linking structure and biological activity of the 
16 
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organophosphates. Schrader (1952) gave the Schraders' 
empirical rule, according to which biologically active 
phosphoric acid esters must possess an "acyl" moiety, and it 
was the first indication that the chemical mechanism of 
insecticidal action might depend upon the phosphorylation of 
biologically important targets. 
In 1937/38 Schrader gave a specific formulation (I, II) 
and in 1950 a somewhac more generalized form (III) of 
organophosphates 
R 2 N ^ ^ 0 ( S ) R^O ^ 0 ( 5 ) R^ 
R l O A c y l R ^ o Acyl r / \ c y l 
(I) (H) (III, 
In 1963 he described his formula (II) as follows: 
"It is likely that a biologically active phosphoric 
acid ester will be obtained when the following pre-requisites 
are satisfied: Either sulphur or oxygen must be directly 
bound to the pentavalent phosphorus, R^ and R2 may be alkoxy, 
alkyl groups or amines while the 'acyl' may be represented by 
anions of organic or it.organic acids, such as fluorine, 
cyanate, thiocynates, enolat^s, mercaptides, etc." 
Numerous substantial arguments were put forward showing 
that the biological activity of organophosphates is to be 
considered as an inhibition of cholinester-splitting and 
other serine enzymes, which chemically undergo 
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phosphorylation of serine-alchohol group at the esteratic 
site. The dependence of the inhibitory effect both upon the 
affinity of the inhibitor for the active centre of the 
enzymes as well as upon the phosphorylation constants means 
that, due to the complex nature of the inhibition potential, 
it is only in very favourable cases that there is a direct 
correlation between tlie inhibition and phosphorylation 
action. 
A 'Phosphorus inhibitor' contains three types of 
groups: (i) The basic or neutral 'R' group, (ii) the acidic, 
acyl group (X) and, (iii) the atom from sixth period of the 
periodic table, usually oxygen or sulphur, doubly bond to 
phosphorus. Each type of the group has a typical effect on 
the activity. Slight structural changes greatly alter the 
spectrum of biological activity. The activity is determined 
by the magnitude of electrophilic character of the phosphorus 
atom, the strength of the P-acyl bond and the steric effects 
of the substituents. 
(i) Basic qroupsi Change in the basic groups produces a 
complex variation in 'rates of inhibition', and this 
variation is different according to whether the enzyme 
inhibited is an AChE or ChF. There is no general relationship 
between the rates at which compounds are hydrolyzed and the 
rates at which they inhibit ChEs, because the effects of the 
basic groups on rates of hydrolysis are mainly 'electronic' 
and on rate of inhibition, mainly 'steric'. 
TdblS 1*4 = structure and neurotoxic action according to 
Aldridge and Bariiis (1967 ). 
1 9 
N e u r o t o x i c 
CI I, \ 
o-
h 
p.o 
N o n - n e u r o t o x i c 
CH.-Oo- P.O 
V o i'-O / Vo- P.O 
ClCHjCKjO^  O 
ClCHiCHjO^  
P 
ClClljClijO^  ""oCH'CCl, 
CH,0^  O P^ 
CHjO'' OCIl'CCl, 
l-C,H,-NH^  O 
i-C,H,-NM F 
(CH3)jN^  O 
(CHj)jN I-' 
i-CjHjO'' F P-O-P l-CjH,0'' O^C,H,l 
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(ii) Acidic groups; When changes in structures are confined 
to the acidic acyl group, X, there is generally close 
correlation between 'rates of hydrolysis* and 'rates of 
inhibition*. Rates of hydrolysis depend primarily upon the 
strength of acidic HX. Exceptions are cyanidates, thiolates 
and phosphate ester containing vicinyl double bonds (P.O.C:C) 
which hydrolyse abnormally rapidly. 
(iii) P.O. and P;S Groups; Thionates are isomerized or 
oxidized readily to more active compounds. The PI50 of 
'parathion' is thus about 4 times less than that of its 
oxygen analogue, *paraxcji'. Perhaps the P:0 oxygen in 
phosphates is hydgrogen bonded to the enzyme surface and this 
facilitates the reaction. Sulphur has much less ability to 
form hydrogen bonds, so the thionates react more slowly. 
Interestingly, the thiono-analogues of ACh and related esters 
are not hydrolyzed by AClirC and other esterases (Bergmann et 
al 1958). 
Biological activity of organophosphates, thus, vary 
with the slight structural changes even in the same group, as 
shown in Table 1.4. 
1.1.4 Mechanism of action of organophosphates 
The central nervous system (CNS) is one of the most 
susceptible and vulnerable regions of the body. Attacking the 
CNS is supposed to be the most rapid and sure way of 
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disturbing the normal body mechanisms. The biological action 
of most of the organophosphate pesticides on mammals and 
insects is generally exerted by attacking the neuronal 
transmission system. The insecticidal action of 
organophosphates in vertebrates appears to result primarily 
from the disruption of nerve impulse transmission in the 
central and peripheral nervous system following inhibition of 
acetylcholinesterase (AChE) leading to accumulation of 
cholinergic neurotransmitter acetylcholine (ACh) at the 
synapses (Johnson 1976). 
1.1.5 Molecular Bechanism of action 
The most significant molecular mechanism of action of 
most the organophosphates is regarded as their action through 
phosphorylation of the active centre of cholinesterase 
(Jaques & Bein 1960). 
The unit structure of AChE is a protein with a 
molecular weight of 80,000. These units are grouped as 
tetramers (Dudai et al 1973; Rieger et al 1973), The active 
surface of the enzyme consists of two sites, an anionic site 
and an esteratic site (Wilson and Bergman 1950). At the 
anionic site (negatively charged, probably due to free 
carboxyl group of dicarboxylic acid), the positively charged 
quaternary nitrogen atom of ACh is attracted by electrostatic 
forces. The esteratic site has essentially two components 
located at 2,5, and 5 A®, respectively, from the anionic 
site: a potentially acidic group (the hydroxyl group of 
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serine) and a basic nucleophilic group (the iinadizole group 
of histidine). The imidazole group, by hydrogen bonding, 
enhances the nucleophilic activity of the serine hydroxyl 
group, thus enabling it to interact with the carbonyl carbon 
atom of ACh. A covalent bond is formed, with the production 
of an acetylated-enzyme intermediate and the release of 
choline. The electrophilic carbon atom of the acetyl group 
then undergoes nucleophilic attack by the electronegative 
oxygen atom of a water ra. ;-cule. The acetyl-enzyme complex is 
thus hydrolysed, producing regenerated enzyme and acetic acid 
(Wilson 1951; 1954). A diagrammatic representation of the 
reaction of ACh with AChL is depicted in Figure 1.1. 
The active organophosphate pesticides act by blocking 
acetylcholinesterase. This inhibition results in accumulation 
of ACh at the post-synaptic membrane so that it becomes 
unable to return to its original (resting) state, and thus 
prevents the smooth transmission of nervous impulses across 
the synaptic cleft, resulting in the loss of muscular 
coordination, induction of convulsions and ultimately death. 
The reaction bet..ec.n AChE and most of the OPs occurs 
only at the esteratic site, but proceeds in the manner 
comparable to the reactic.» between AChE and ACh (Fig.1.1). If 
the resultant phosphorylated enzyme is extremely stable: if 
the attached alkyl groups are methyl or ethyl, significant 
regeneration of the enzyme by hydrolytic cleavage requires 
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several hours. Some OP compounds (e.g. ecothiophates), 
however, combine at both the esteratic and anionic sites, 
which probably contributes to their extreme potency and 
specifity. 
1,1.6 Mechanism of Nerve Transmission 
The central nervous system (CNS) comprises of brain and 
spinal cord. The modes of communication between CNS and the 
rest of the body are through the peripheral nervous system. 
The communication channel is through cable lines of axons 
derived up from many neurons. Neuron, the basic structural 
unit of the nervous system, comprises the nerve cell body 
together with all its processes. The simplest neural action 
in vertebrates involves Lhe participation of several neurons 
which form a common functional pathway. This functional 
conjugation is established via the synapses, consisting of a 
pre-synaptic membrane 'lu:-.ally an axon, rarely a dendrite) 
and a post-synaptic membrane (cell body, a dendrite or 
occasionally an axon), 20-30 nm apart. 
The transmission of nerve impulse is an electrochemical 
process in which monovalent ions act as carriers of the 
current (Fig 1.2). Propagation of nerve impulse and the 
perturbation in the permeability of the axon membrane occurs 
simultaneously. The interior of the axon has larger amount of 
potassium (K) than sodium (Na) ions, while the fluid outside 
possesses an opposite composition. When a nerve impulse is 
generated, a flood-gate ens and the sodium ions rush into 
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the axon, making the interior mileu locally positive. After 
the passage of the nerve impulse, the sodium gate closes and 
opens a potassium gate allowing for the efflux of K"*" ions and 
restoring the normal negative potential (Castillodel & Kotz 
1957; Eccles 1957) . The chemical transmitters carry the 
electrical potential across the gap between the pre-synaptic 
and post-synaptic membranes, called as "synaptic junction". 
The arrival of the nerve impulse at pre-synaptic membrane 
triggers the release of neurotransmitter, acetylcholine, from 
the 'vesicles' or storage sites located in pre-synaptic 
cells. ACh gets attached to a .'binding site' on the post-
synaptic membrane after passing through the synaptic cleft 
(Fig 1.3). The neuromuscular junctions of the sympathetic 
system are stimulated by adrenalin or noradrenalin. It is 
however, possible that the adrenergic mechanism, too is set 
into motion primarily Ly ACh. In order to bring the ACh-
induced action potential back to the resting state, and 
therefore facilitating the transmission of a new impulse, the 
liberated ACh is immediately broken down to acetic acid and 
inactive choline by the hydrolytic enzyme, AChE. A second 
enzyme, choline-o-acetyltransferase (Plorkin & Stolz 1964) 
is capable of esterifying both compounds to acetylcholine 
again. 
The inhibition of AChE leads to the accumulation of ACh 
at the synapses, thus preventing smooth transmission of nerve 
impulses across the synaptic cleft (Jonson 1976). 
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1.1.7 Organophosphate Poisoning 
The ever-increasing and indiscriminate use of 
organophosphates as pesticides, besides improving the 
agricultural yield, has been found to produce various 
toxicities in man and other non-target organisms (Hall & 
Kolbe 1980, Hasan and Ali 1981, Islam et al 1983, Tayyaba & 
Hasan 1985, Naqvi et al 1988, Khan and Hasan 1988, Naqvi & 
Hasan 1990, Katoh et al 1990, Tracey and Gallagher 1990, 
Naqvi and Hasan 1991 a,b&c) . 
Man is generally exposed to OP compounds either by 
consuming food grains, fruits and water contaminated with 
OPS, or while manufacturing, testing or spraying OP 
pesticides in the agricultural fields. 
Some usual signs and symptoms of organophosphate 
poisoning in mammals are defaecation, urination, lacrimation, 
muscular twitching, fasciculations and convulsions, etc. 
(O'Brien 1960). The broad spectrum of OP-induced effects of 
the CNS include confusion, ataxia, slurred speech, loss of 
reflexes, generalised convulsions, central respiratory 
paralysis and coma. 
The time of death following single acute exposure may 
range from less than five minutes to nearly twentyfour hours. 
The mechanisms involved in the death have been described by 
O'Brien (1960) as bronchoconstriction, lowered blood 
pressure, neuromuscular blockage of respiratory muscles and 
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failure of respiratory system. The sequence of events is as 
follows 
- inhibition of ChE 
- ACh accumulation at the synapses 
- Disruption of nerve impulse 
- Respiratory failure, and 
- Death 
1.1.8 Reports available on OP poisoning: 
Numerous cases of OP poisoning in man have been 
reported from various parts of the world. The greatest of 
which was reported froHi Japan where 19, 436 cases of OP 
poisoning were registered during 1954-1970 (Ministry of 
Health & Welfare, Japanese Government 1954-1970). In Denmark 
273 deaths were reported in six years. About 286 cases of OP 
poisoning occurred in Finlcnd in six years (Toivonen et al 
1959) . Around 1950 dea' i.- v,'ere registered in California in 
four years (Department of Public Health, State of California, 
1959-1960). A study in Brazil revealed 3,445 cases of 
poisoning with 208 deaths during 1957-1979. In Mexico, four 
deaths were reported among 847 cases of poisoning in the 
agricultural workers in 1974. Twelve deaths were registered 
in 1987 in the agricuJtural workers of Punjab (Indian 
Express, July 22 1987). 
Quite a large nuniLer of other fatal cases of 
organophosphate poisoninc^ nave been reported from all over 
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the globe (Vercruysse & ueslypere 1964; Gitelson et al 1965; 
Francis et al 1982; Vasilescue et al 1984, Tracey & Gallagher 
1990) . 
In addition to these cases of accidental intoxication 
which resulted from use and manufacture of OP pesticides, 
these compounds have also been used quite often for homicidal 
and suicidal purposes, h study revealed that about 50-80% of 
poisons detected in 1969 from medicolegal cases in India 
belonged to organophosphate and organochlorine group of 
pesticides (Bami 1971). 
1.2.0 Dimecron 
"Dimecron", commonly known as phosphamidon, is a potent 
and commonly used systemic organophosphate insecticide 
belonging to the group of enol phosphates, also known as 
vinyl phosphates. 
Phosphamidon was first synthesized in 1955 by E. 
Beriger, working in the laboratories of CIBA Ltd, Basle. The 
first screening trials revealed its most important features, 
systemic insecticidal acti\'ity; Low phytotoxicity; solubility 
in water; and lack of smell. Since it possessed these 
properties, phosphamidon .;as recognized as being particularly 
suitable for use as a plunt protection agent. It has since 
become familiar under the name 'Dimecron' following several 
years of practical application in many countries. 
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1.2.1 Physico-chemical p.^perties 
Common name : Phosphaml,jn 
Chemical name : 2-chloro-2-diethylcarbamoyl-l-methylvinyl 
dimethyl phosphate 
Structural formula : 
CH3-0 /.O ^^ 
/ ^0-C=C-CO-N< CH3-O 
CH3 C^H, 
Empirical formula: C^o H^g O5 N CI P 
Molecular weight ; 299.7 
Specific gravity : d^S^ = 1.2132 
Refractive index : n^S^ = 1.4718 
Boiling point : 0.04 mm Hg 940c 
0.2 mm Hg IIS^C 
1 mm Hg ISQOC 
Vapour pressure : 20°C 2.5.10~5 nun Hg 
30OC S.H 10-5 mm Hg 
40OC 2.6.10-4 mm Hg 
Volatility : 20OC 0.41 mg/m^ 
30OC 1.33 mg/m3 
40O C 4.00 mg/m3 
Solubility: miscible with water and all organic solvents 
except saturated hydrocarbons, in which it is 
soluble onlj 'o a limited extent. 
Viscosity : 25° = 70 Cp. 
Colour Colourless tale yellow (commercial form is 
coloured violet by the addition of dye 
for safety p. poses) 
Odour : faint, pleasant 
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1.2.2 Synthesis, isomers 
Phosphamidon is synthesized by condensing 
halocarbonyl compounds with trialkyl phosphites, according to 
the Perkow reaction (Lichtentahler 1961). The general 
equation can be represented as follows: 
CH3O CKl '^'BOsp^ ^^  V 
CH 0 V * 0 = C - C - C 0 - N ^ 0 - C = C - C 0 - N ( C , H , W C h , C l 
3 / I 2 5 2 3 I 2 5 2 3 
CH3O CH3 CH3 
This reaction gives two isomers, the -isomer (cis-
phosphamidon) and -isomer (trans-phosphamidon), which 
differ in the arrangement of the substituents at the C=C 
double bond: 
CH 0 CH 0 0 
/ < X CI 
CH3O CH3O o -c=c( 
CI C 0 - N ( C 2 H 5 ) 2 
These two isomers differ as regards biological activity. The 
insecticidal activity of the -isomer which accounts for 70% 
of technical grade phosphamidon, is several times greater 
than that of the -isomer. Similarly -isomer possesses 
more potent anticholinesterase activity. 
1.2.3. Metabolism 
Various studies have revealed three ways in which 
phosphamidon is broken down in biological substrates (Anliker 
et al 1961). By the first process, phosphamidon is hydrolysed 
to give dimethyl phosphoric acid and N, N-
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diethylchloroacetoacetamide; the latter is then decomposed in 
an acid environment to give chloroacetone/ carbon dioxide, 
and diethylamine. In the alkaline environment, first of all 
hydrochloric acid is formed and then, considerably more 
slowly, acetic acid, the final product being glycolic acid 
diethylamide. 
CHgO^ CI CH3O 
CH3 
By the second :aocess, the phosphate group is 
demethylated to give- Jisimethylphosphamidon; this process 
can, in theory, also be regarded as hydrolysis, but in 
practice is probably moic complicated: 
CH3O'' ^ 0-C=C-C0-N(C2H5)2—H 0 ^0-C=C-C0-N (C2H5)2 
C H 3 C H 3 
The third process consists of the removal of one ethyl 
group from the acid amide. The resultant desethyl 
phosphamidon is further broken down to give N-
ethylchloroacetoacetamide, which is again decomposed into 
smaller compounds: 
C H 3 O , 0 CI CI 
C H 3 O O - C r C - C O - N I C j H j l J ^ C H j ' j ' • • - - f c C - C O - N H ( C 2 H 5 ) 
CH3 CH3 ^ 
P^  •CH-CO-CH-CO-NH IC2H5) 
CH,0 OH ' 3 - CI 
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1.2.4 Toxicology 
Dimecron, being an organophosphate pesticide, as such 
possesses the biological property of inhibiting the enzyme 
acetylcholinesterase (AChE) (Klotzshe 1958, Jaques & Bein 
1960, CIBA monograph 1967). Various neurochemical and 
neurobehavioural effects of dimecron have been reported 
(Gitelson et al 1965, Naqvi et al 1988, Naqvi & Hasan 1990 
1991a,b,c). 
The no-effect level of dietary intake of pesticides 
established for the most sensitive animal species is taken as 
a basis for calculating an "acceptable daily intake" (ADI) 
for man. It is defined as "the daily dosage (expressed in mg 
of the chemical present in the food per Kilogram body weight) 
which during an entiire life time appears to be without 
appreciable risk on the ba^is of all the facts known at that 
time". This definition f^ as formulated by the Food and 
Agriculture Organization (FAO) committee on pesticides in 
agriculture, and the VvHO expert committee on pesticide 
residues (FAO/WHO 1964). Toxicological investigations have 
shown that in the rat and dog, the no-effect level of 
dimecron as regards growth rate, pathological and 
histopathological findings, blood and renal and liver 
function, is of the order of 2.5 to 5 mg in the food Kg"^ / 
day. Dividing this by the safety factor of 100 gives an ADI 
for man as 0.025 mg / Kg 'CJba monograph 1967). On the 
other hand, the cholines. . se no-effect level of 0.1 to 0.5 
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mg / Kg / day, divided by the safety factor 10, gives an ADI 
for man of 0.01 mg / Kg, equivalent to the daily ingestion of 
0.5 mg by an adult weighing 50 Kg. 
Interestingly, Naqvi and Hasan (1990) have reported 
dose-related accumulation of dimecron and its metabolite 
desethylphosphamidon in the CMS regions of rats treated with 
graded doses (1.0, 1.5 and 2.0 mg Kg"^ b.wt, ip) of dimecron 
for seven days. 
1.2.5 Signs and symptoms: 
Phosphamidon has been found to induce the signs and 
symptoms of poisoning similar to those produced by most of 
the other anticholinesterase organophosphate compounds. A 
list of sings and symptoms of general anticholinesterase 
poisoning (Holmstedt 1959; WHO 1962) is given in Table 1.5. 
TABLE 1.5 
Site of action Signs and symptoms 
(a) Following local exposure 
- Pupils : Miosis, marked, usually 
maximal, sometimes unequal. 
- Ciliary body : Frontal headache, eye pain on 
focussing, dimness of vision, 
nausea and vomiting. 
- Nasal mucous membrane : Rhinorrhoea, hyperaemia. 
- Bronchial tree : Tightness in chest, 
bronchoconstriction, cough. 
Table 1.5 c o n t d — 
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Sweat glands 
Striated muscles 
; Sweating at site of exposure. 
: Fasciculations at site of 
exposure 
(b) Following systemic absorption: 
Bronchial tree j 
Gastrointestinal system 
- Sweat glands 
- Salivary glands 
- Lachrymal glands 
- Heart 
- Pupils 
- Ciliary body 
- Bladder 
- Striated muscle 
- Central nervous system 
Tightness in chest, 
bronchoconstriction, cough, 
slight pain in chest, increased 
bronchial secretion. 
: Anorexia, nausea, vomiting, 
abdominal cramps, epigastric 
and substernal tightness, 
diarrhoea, involuntary 
defecation. 
: Increased sweating. 
; Increased salivation. 
Increased lachrymation. 
Slight bradycardia. 
Slight miosis 
blurring of vision 
Frequent or involuntary 
micturition 
: Easy fatigue, muscular 
twitching, fasciculations 
: Giddiness, tension, anxiety, 
restlessness, excessive 
dreaming, headache, tremor, 
drowsiness, confusion, 
slurred speech, ataxia, 
convulsions, coma, depression 
of respiratory and circula-
atory centres, fall in blood 
pressure. 
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1.2.6 Treatment: 
Phosphaitiidon poisoning can readily be antagonised by 
the use of known antidotes of organophosphorus cholinesterase 
inhibitors, such as atropine and PAM (2-pyridine aldoxime 
methyl iodide). Furthermore, an antioxidant agent, 
acetylhomocysteine thiolactone, commonly known as cithiolone, 
has also been reported to protect against experimental 
phosphamidon toxicosis (Hasan et al. 1987, Naqvi and Hasan 
1991a). d 
^ NH-C-CH3 
structure of Cithiolone 
1.3.0 Open field Behaviour (OFB) 
It is well known that changes in the biochemical 
mechanism and amine concentrations in the CNS may lead to 
varying disorders in behaviour (Taylor and Snyder 1971). A 
number of CNS active drugs and chemicals have been found to 
alter the open field behaviour on acute poisoning. Depending 
upon the site and mechanlsin of action, various OFB parameters 
i.e. ambulation, rearing and preening show varying disorders. 
Ambulation is described as horizontal (simple) 
stereotypy (Dandiya et al 1969). It is indicative of intact 
muscular coordination. Rearing is a vertical (complex) 
stereotypy, and dopamiii<= plays an important role in its 
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control (Gupta and Holland 1972). It is indicative of 
cortical stimulation (Lat 1965). Preening is a behavioral 
response and has been said to be a behavioural correlate of 
cortical stimulation (Gupta et al 1971). 
Ali et al (1980) have correlated varying perturbations 
in the open field behaviour with altered monoamine levels in 
the brain following organophosphate dichlorvos toxicosis. 
1.4.0 Acetylcholinesterf . ( A C h E ) 
Acetylcholinesterase is manufactured in cholinergic 
cell bodies. It is delivered to the synapses by axonal 
transport. It is the most important cholinesterase enzyme, 
which hydrolyses the cholinergic neurotransmitter, 
acetylcholine (Ach) at the synapses after transduction of 
nerve impulses, thereby, paving the way for the smooth 
transmission of nerve impulses. Koelle (1963) noted that the 
only part of the AChE of brain behaves as if it were 
accessible to quaternary substrates and inhibitors. He 
supposed that this fraction of the enzyme (functional AChE) 
is outward facing, and the remainder (reserve AChE) is inward 
facing and in transit. The ability of peripheral 
cholinergically innervated tissue to form surplus ACh 
(Collier & Katz 1971) in the presence of an 
anticholinesterare suggests that at least a small part of the 
enzyme transported by peripheral axons is still in the 
reserve orientation as it nears the synapses, cerebral 
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cortex, which seems to have less of that ability, may possess 
only functional AChE. 
Most tissues contain several forms of AChE (Haubrich & 
Chippendale 1977; Bon et al 1979). These are catalytically 
identical glyerproteins, but they differ in molecular weight, 
ease of extraction and physical properties. In order of 
increasing size, they are a monomer of about 65,000 daltons, 
the likely precursor of other forms; a dimer and a tetramer, 
which are partly in solution and partly membrane bound; and 
several asymmetric species that have a cluster of monomers 
attached to a collagen tail. In neurons, the enzyme is 
transported along the axon and eventually externalized; when 
this happens part remains attached to the neurilemma, but 
part is secreted into the extracellular space (Skau & 
Brimijoin 1978). At nicotinic junctions the collagen-tailed 
variants predominate; they are not membrane-bound, but reside 
in the synaptic cleft. 
The active center of each enzyme subunit has been 
described as incorporating "anionic" and "esteratic" sites 
which fit respectively tlie cationic trimethyl cluster and the 
ester carbonyl of ACh, but binding at the anionic site 
depends more on hydrophobic than on coulombic reaction. The 
esteratic site incorporates a serine side-chain, like many 
hydrolytic enzymes; a histidine imidazole is also present. 
The irreversible (or very slowly reversible) 
organophosphates, including important pesticides as well as 
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nerve gases, inactivate the AChE through binding themselves 
to the esteratic site of the enzyme, and thus phosphorylating 
the serine hydroxyl (Hall & Kolbe 1980). This leads to the 
accumulation of ACh at the synapses, causing disruption of 
smooth nervous transmission (Murphy 1980). A detailed 
mechanism of inhibition of AChE by organophosphates has been 
given in an earlier section (1.1.5), Kinetic studies of the 
enzyme indicate a three-step reaction with AChE (Fig 1.4). 
E E(ACh) A C e t y l - E E 
t • 1 
ACh Cho ine H , 0 A c e t i c Ac id 
The final deacetylation is probably the rate 
controlling step. AChE is one of the fastest enzymes, with a 
turnover number higher than 10"^ sec"^; but its velocity 
falls off at high substrate concentrations, because of the 
increased probability that two ACh molecules might attach at 
a single active centre and thus prevent each other's 
hydrolysis (substrate inhibition). 
Acetylcholine (ACh), unlike norepinephrine and other 
neurotransmitters, is not recaptured to any extent by the 
nerve endings that have released it, only the choline derived 
from its breakdown can be taken up and reused. So, AChE has a 
double function: on the postsynaptic site, it prevents 
released ACh from acting longer than it is necessary; and on 
the presynaptic site, it helps to ensure an adequate supply 
of choline for ACh syntheFis. 
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A number of studies have revealed that most of the 
organophosphate pesticides inhibit the AChE activity in the 
brain. The variations in the extent of toxicity of various OP 
compounds are supposed to be due to variations in the rate of 
their enzymatic hydrolysis (March et al 1956). DuBois et al 
(1949) observed that rats poisoned with OP, parathion, showed 
reduced cholinesterase activity. Paul et al (1979) observed 
malathion-induced inhibition of AChE. Studies of Tsumuki et 
al (1970) reveal AChE inhibition by dimethoate, sumithion and 
trichlorfon, in varying proportions depending on the level 
of, and duration of the pesticide treatment. Diazinon has 
been reported to inhibit ChE activity in the CNS and other 
organs (Weiss et al 1964) and increase the level of ACh in 
the brain (Kar and Matin 1971), resulting in stimulatory 
effects, tremors and convulsions. Ali et al (1977) reported 
diminution of AChE in the rat brain following dichlorvos 
intoxication. Most of the earlier workers were of the view 
that OP-induced AChE inhibition is irreversible, but Aldridge 
(1953) reported a recovery in the AChE activity following its 
depletion by organophosphate triesters. The studies of 
Nagaratnamma & Ramamurthy (1983) in Cryrinus carpio with 
methyl parathion also indicate rapid recovery of brain AChE. 
Although abundant literatu.f is available on the effects of 
various OPs on the AChE, the neurotoxic effect of dimecron on 
the brain AChE has not bcei. reported so far. 
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1.5.0. Honoamines 
Monoamines/ consisting of catecholamines (CA) and 
serotonin (5-HT) act as important neurotransmitters in the 
brain. Localized in the nerve fibres and nerve terminals, 
they are universally distributed in the CNS, especially in 
the regions to which autonomic or vegetative functions are 
attributed (Friede 1966). 
The catecholamines: dopamine, norepinephrine and 
epinephrine, are neurotra.ismitters, concerned with a number 
of functions related to emotion, attention and visceral 
regulation. Although dopamine (DA) serves as the precursor 
for norepinephrine (NE), and NE may be N-methylated to form 
epinephrine, the three monoamines have separate localizations 
in distinct neuronal pathways (Coyle & Snyder 1981). The 
cell bodies of dopaminergic neurons are located primarily in 
the mid-brain, while the noradrenergic neurons cluster in the 
medulla oblongata, pons and mid-brain, in particular locus 
coeruleus of the floor of fourth ventricle. 
Catecholamines are concentrated within storage vesicles 
that are present in high density within the nerve terminals. 
Ordinarily low concentrations of the catecholamines remain 
free and unprotected in the cytosol. Thus, during 
biosynthesis, conversion of tyrosine to L-dopa and L-dopa to 
dopamine occurs in cytosol. Dopamine, then is taken up within 
the storage vesicles. For the noradrenergic neurons, the 
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final hydroxylation occurs within the vesicles. The mechanism 
that concentrates the catecholamines within the vesicles is 
an ATP-dependent process linked to a proton pump (Holz 
1978). The vesicles play a dual role: they maintain a ready 
supply of catecholamines at the terminal, and they mediate 
the process of their release. When an action potential 
reaches the nerve terminal, calcium (Ca"^ "*") channels open, 
allowing an influx of the cation into the terminal; increased 
intracellular Ca^ "'" promotes the fusion of vesicles near the 
synaptic specialization with the neuronal membrane. The 
vesicles then discharge their soluble contents, including NE, 
AT and DBH, into the extraneuronal space (Coyle & Snyder 
1981). Inspite of marked fluctuations in the activity of 
catecholaminergic neurons, the levels of catecholamines 
within the nerve terminals remain relatively constant. 
Through such mechanisms as end-product inhibition, transient 
activation, and enzyme induction, the neuron can accommodate 
to alterations in utilization of catecholamine 
neurotransmitters (Joh et al 1978). The action of 
catecholamines released at the synapse is terminated 
primarily by reuptake into the nerve terminals that release 
the neurotrasmitters. Catecholamines that have not been 
removed from the synaptic cleft by the transport process 
diffuse into intracellular space, where they are catebolized 
by the enzyme, monoamine oxidase (MAO) and cathecol-o-methyl 
transferase (COMT) (Fig 1.5). The catecholamine reuptake 
process was discovered by Axelrod (1971). 
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Serotonin or 5-hydroxy tryptamine (5-HT) is widely 
distributed in the body of coelenterates, arthopods, 
molluscs, tunicates and vertebrates. Like acetylcholine and 
catecholamines, serotonin acts on many body organs either 
directly or by a neuronal reflex. Its actions on the 
cardiovascular, respiratory and gastrointestinal systems are 
especially prominent. 
The CNS contains a relatively small amount (about one 
percent) of the serotonin in the body. The distribution of 
serotonin in the brain is uneven. The brain-stem has the 
highest concentration, thfc cerebral cortex has moderate while 
cerebellum has a low concentration (Saavedra et al 1973). A 
family of neurons in the pons and mesencephalon is the 
primary source of serotonin in the brain (Michael 1981). 
These neurons are found in or near the midline, or in the 
raphe nuclei, in clusters. Sertonin is stored in synaptic 
vesicles in nerve endings, it appears to be synthesized 
outside the vesicles and then taken into them (Joh et al 
1975). Finally, it is released by an exocytotic process. The 
most important enzyme in ^^.tabolising serotonin is monoamine 
oxidase A, which oxidii.t. the amino group of serotonin to 
form an aldehyde, 5-hydi, .Indoleacetaldehyde, which usually 
oxidizes to yield 5-hydroxyindoleacetic acid (5 HIAA) (Fig. 
1.6). Enzymatic degradation by MAO helps to limit the 
biological actions of 5-Hi' (serotonin), so does reuptake into 
nerve terminals. Both serotonergic and other monoaminergic 
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terminals can take up "i Occupation of presynaptic 5-HT 
"autoreceptors" on sero-onin-containing neurons reduces the 
neuron's rate of spontaneous firing . This provides a 
mechanism for feedback inhibition of neuronal activity that 
is coupled to the release of transmitter. 
5-HT has been implicated in numerous central processes, 
including regulation of the anterior pituitary, sleep, 
perception of pain, thermoregulation, control of blood 
pressure, appetitive behaviour, drinking, respiration, 
heart-rate, rhythmic behaviour, and behaviour. 
Some of the organophosphates e.g. parathion (Fiscus & 
Van Meeter 1977) and dichlorvos (Ali et al 1980) have been 
reported to purterb the levels of monoamines in the brain. 
However, no report is available todate on the effect of OP 
dimecron on the monoamir . ^ 
1.6.0 Monoamine Oxidases 
Monoamine oxidase (MAO) is an important neuronal enzyme 
that is primarily responsible for the catabolic inactivation 
of monoamines. It is a flavin-containing enzyme located on 
the outer membrane of the mitochondria (Costa & Sandler 
1972). MAO catabolically degrades monoamines by oxidatively 
deaminating them to their corresponding aldehydes, in turn, 
these can be converted to-* analogous acids by aldehyde 
dehydrogenase (Cooper et al 1978). Role of MAO in the 
catabolism of monoamines is depicted in Figures 1.5 and 1.6 
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MAO catalyzes the following reaction: 
RCH^ CHjNHj* • H2O ^ RCHj CHO •H^ O^ t NH^ 
Because of its intracellular localization, MAO plays a 
strategic role in inactivating catecholamines that are free 
within the nerve terminal and not protected by the storage 
vesicles (Coyle & Snyder i981). Isoenzymes of MAO have been 
characterized with dif- substrate specificities; MAO-
A preferentially deaminates NE and 5-HT, whereas MAO-B acts 
on a broad spectrum of phenyl ethylamines. 
It is well known that biogenic amines are involved in 
the regulation of certain activities of the central nervous 
system (Chase & Murphy 1973), Any change in the normal amine 
concentration will disturb their activities and result in 
convulsive seizures (Kilien & Frey 1973). Organophosphate 
pesticides have been reported to deplete the brain monoamine 
levels (Ali et al 1980= Irezezinsky & Parus zewska 1980; 
Naqvi & Hasan 1991c). A so, OPs have been found to be MAO 
activators (Ravi 1984, 'aqvi & Hasan 1991b). When treated 
with a MAO activator, the synthesis of monoamine is 
essentially unaffected bjt due to enhancement in the 
degradation of amines, a net decrease in the amine 
concentration is observed iSourkes 1981). 
47 
1.7.0 Brain Lipids 
Among various body organs, the brain is one of the 
richest in lipids. Studies of lipids in the nervous system, 
are therefore, a vital part of the neurochemical 
investigation due to the immense importance of lipids in the 
brain, both as structural constituents and as participants in 
the functional activity of the brain. Lipids account for 
about half the dry weight and most of the structural 
architecture of membranes in the brain (Brante 1949; Ordy & 
Kaack 1975, Suzuki 1981). Brain contains a unique structure, 
the myelin sheath, which has the highest lipid concentration 
of any normal tissue or subcellular components, except for 
adipose tissue. Total lipids make up about 65% of the dry 
weight of white matter and 35 to 40% of the gray matter 
(Brante 1949). Myelin sheath contains about 65% of the lipids 
of whole white matter. Myelin is present in all parts of the 
CNS, but is more concenLrated in areas composed mainly of 
fiber tracts, such as ti-.e v.jite matter of brain and spinal 
cord and in peripheral i.erves, such as sciatic nerve. 
Different types of membranes accumulate different types of 
lipids (Horrocks et al 1975) . There is increasing evidence 
that lipid molecules play important functional roles within 
the membranes. Some of the postulated physiological functions 
of membrane lipids include the site for the cell-to-cell 
recognition process, specific cell-surface antigens, and 
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specific receptors for toxins or other physiological 
compounds. 
The lipid composition of the brain is relatively stable 
throughout adult life. However substantial changes in lipid 
composition take place during active myelination. In active 
myelination, the brain loses water, predominately in white 
matter, the lipid content increases rapidly and the 
differences between gray and white matter become more 
apparent (Wells & Dittmer 1967; Norton & Poduslo 1973). The 
rapidly increased myelin content is related with increase in 
brain weight (Smith et al 1983). Cumings (1955) compared the 
lipids of demyelinated lesions in multiple sclerosis with 
those of normal areas of the brain and found a decrease in 
sphingomyelin, cerebroside and free cholesterol. 
Phosphoglycerides, cholesterol and galactolipids are present 
in mature myelin sheath^ with the mole ratio of 3:4:2 
respectively. Gangliosides are localized primarily in plasma 
membranes (Karpova 1978) bat monosialoganglioside is present 
in limited quantity in myelin fractions (White et al 1978). 
Most of the membrane lipids exist in a "bilayer form" 
according to 'Fluid Mosaic" model of Singer and Nicolson 
(1972) . The physical state of the lipid plays a critical role 
in directing the conformation and function of the membranes. 
The lipid bilayer of the membranes is predominantly composed 
of phospholipids and variable amounts of cholesterol and 
glycolipids (Tanford 1978). 
There is good deal of experimental evidence to show 
that organophosphates influence lipid synthesis in the brain 
(Majno & Karnovsky 1955). Organophosphates not only influence 
the lipid metabolism, but also alter the lipase activity 
(Caley and Jenson 1973; Islam et al 1983), Nelson and Barnum 
(1960) observed the inhibition of phospholipid biosynthesis 
after toxicosis with OP pesticide, di-isopropyl 
phosphorofluoride. Previoas studies from this laboratory have 
revealed perturbations in different brain lipid levels 
following exposure to various OP pesticides, viz, dichlorvos, 
metasystox, methyl parathion (Tayyaba & Hasan 1980; Islam et 
al 1983; Tayyaba & Hasan 1985; Vadhwa & Hasan 1986, Hasan & 
Khan 1985; Khan & Hasan 1988). In the present study, effect 
of OP, dimecron on the lipid levels in the CNS have been 
investigated because, to date, no report is available on the 
neurotoxic effects of dimecron on brain lipids. 
1.7.1 Phospholipids 
Phospholipids are the primary lipid components of 
plasma membranes, organic membranes and myelin membranes. The 
importance of these phosphorus containing lipids in the CNS 
presumably depends upon Laeir role as membrane constituents. 
Phospholipids constitute approximately one-fourth of the dry 
weight of brain (White 1973). They account for 4.1% of fresh 
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weight and 22.7% of dry weight of the gray matter, and 7.2% 
of fresh weight and 25.2% of dry weight of the white matter 
(Suzuki 1981). The lipids of mammalian CNS myelin are 
composed of 4.6% phospholipids and hence it is proposed that 
phospholipids are the characteristic components of myelin 
sheath (Fumagalli & Paoletti 1963). The metabolically active 
polyphosphoinositides are located in the excitable membrane 
of the neuron, particularly the axolemma. Phospholipids not 
only constitute the backbone of biomembranes, but also 
provide the membrane with a suitable environment, fluidity 
and ion permeability. Porcellati (1983) reported that 
different phospholipids turnover at different rates with 
respect to their structure and localization in various cells 
and membranes. Newly synthesized phospholipds are transported 
to membranous structures by phospholipid exchange and 
transfer proteins (Demel et al 1984) which are found in the 
cytosol. The distribution of phospholipids in biological 
membranes is thus regulated not only by the activities of 
enzymes involved in their metabolism but also by the 
transport and incorporation processes into the membrane. 
Metabolic pathways of phospholipids in brain are similar to 
those in systemic organs (Rossiter 1966) and are depicted in 
Fig.1.7. 
Several organophosphates have been reported to deplete 
the level of phospholipids in the CNS (Nelson and Barnum 
1960; Tayyaba & Hasan 1985? Hasan & Khan 1985; Vadhva & Hasan 
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1986, Naqvi et al 1988). As per the available literature, 
however, dimecron has not been much studied regarding its 
neurochemical effect on ',he phospholipids. 
1.7.2 Cholesterol 
Widely distributed in other body organs, cholesterol is 
found in highest concentration within the central and 
peripheral nervous systems. Cholesterol accounts for about 
10% of dry weight of the brain as compared to less than 1% 
found in most of the otr.ci organs. This high cholesterol 
level seems to be characteristic of nervous tissue (Ansell & 
Hawthorne 1964). Unesterified cholesterol has been suggested 
as a lipid characteristic of myelin sheath, as it occurs in 
white matter in a higher concentration than in gray matter 
(Johnson 1949; Brante 1949) . Cholesterol constitutes 
approximately 25% of myelin lipid by weight (Soto et al 1966) 
and about 70% of total Liain cholesterol is present in myelin 
(Laatsch et al 1962). c no.lesterol is thought to act as a 
conveyer in the absorption of fats. Bloor (1943) reported a 
parallelism between cholesterol content of blood and the 
fatty acids. Due to the abundance of cholesterol in nervous 
tissue and its variation in mental diseases, it may function 
as an insulating medium for myelin sheaths. Adams (1961) 
indicated a strong reaction in the myelin sheath of 
peripheral nerve and fibre tracts of the brain. Sterols are 
thought to have a role in maintaining the balance between the 
cell permeability and the membrane equilibrium of living 
53 
cells. Paoletti (1971) h.is described microsomes as the 
subcellular site of cholesterol biosynthesis in brain. 
Cholesterol biosynthesis takes place in the brain through the 
same pathway as in systemic organs {Suzuki 1981) . Acetate and 
its precursors are transformed through mevalonic acid to 
cholesterol (Fig.1.8), Desmosterol, the immediate precursor 
of cholesterol, is known to be present in brain in measurable 
amounts just prior to myelination (Paoletti et al 1965) and 
also in the myelin sheath itself in the early stage of 
myelination (Smith et al 1967) Biosynthesis of cholesterol in 
brain is most rapid during active myelination, but adult 
brain retains the capacity to synthesize cholesterol when 
precursors, such as acetate or mevalonate are available. 
Previous studies indicate that certain organophosphate 
pesticides perturb the cholesterol contents in various CNS 
regions (Tayyaba & Hasan 1980; Islam et al 1983; Nag & Ghosh 
1984; Rao & Rao 1984; Tayyaba & Hasan 1985; Hasan & Khan 
1985; Vadhva & Hasan 1986; Naqvi et al 1988). To our 
knowledge, to date, no attempt has been made to study the 
neurotoxic effects of dimecron on the cholesterol levels. 
1.7.3 Gangliosides 
Gangliosides are defined as sialic acid-containing 
sphingoglycolipids. Sialic acid is the generic name for N-
acylneuraminic acid, and the acyl group of sialic acid in the 
human brain is always the acetyl form. (Suzuki 1981). N-
acetylneuraminic acid is commonly abbreviated as New NAc 
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(Fig.1.9). The series :;£ gangliosides in the brain has the 
ceramide rligohexosides as the backbone, with one or more 
Neu- NAc moieties attached. Major gangliosides of the brain 
are GMl, GM2, GM3, GDla, GDlb GTl. Several other minor 
gangliosides have been identified in the nervous system, 
including GD3, GD2, and sialylgalactosylceramide. 
Gangliosides are the essential constituents of the cell 
membrane. They are more concentrated in the CNS than in other 
body organs (Svennerholm 1980, Rahman 1983). In the gray 
matter, 6% of the totc.l lipids are gangliosides (Lehninger 
1984). Also, gray mai.ter contains many times higher 
ganglioside concentratiuii, compared to white matter (Wolfe 
1972). Moreover, at the cellular level in the brain, 
gangliosides are more highly concentrated in the neurons than 
in the glial cells and myelin (Roberts 1975, Ledeen 1978, Yu 
& Iqbal 1979) . Regional differences in ganglioside patterns 
of the nervous system have also been recognized. In adult 
nervous system, the individual gangliosides have been 
suggested to play a role as membrane-bound receptors or co-
receptors for toxins, druj,, viruses, hormones, transmitters 
etc. (Svennerholm 1980) .Ithough no convincing evidence is 
available linking ganglio : :.gs to specific neuronal function, 
they may be involved in synaptic transmission (Rahman et al 
1982), owing to their binding capacity for calcium (Probst et 
al 1979) and transmitters (Richardson et al 1982). 
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Brain Ganglioside? are biosynthesized by sequential 
additions of tnonosacchardies or Neu NAc to the carbohydrate 
chain, starting from cernmide (Fig.1.10) (Kaufman et al 1967, 
Ledeen & Mellanby 1977), The biosynthetic steps are catalysed 
by either sialyl or glycosyl transferases that are generally 
specific for the respective reactions. Although the bulk of 
the synthetic activities are localized in the microsomal 
fraction, there is evidence to suggest that some ganglioside 
sialyltransferase may also be present in nerve endings 
(Suzuki 1981). Degradation of brain gangliosides also 
proceeds by sequential removal of monosaccharide and Ncu NAc 
(Fig.1.10) by glycosidases and neuraminidases (Ladeen & Yu 
1973); Ledeen and Mellanby 1977). Most of these hydrolytic 
enzymes are localized .ih lysosomes, wherein the catabolic 
processes of cellular constituents are believed to occur 
(Sandhoff & Christmanouf ^ i:--79) . 
Because of the high concentration in the neuronal 
membrane (Ledeen 1978) and the unusual chemical structure of 
both hydrophilic and hydrophobic chains, the physiological 
functions of brain gangliosides, such as their static role as 
membrane constituents, and their possible involvement in ion 
transport and nerve transmission, have been the subject of 
speculation. GM^ can affect neurotransmitter receptors with a 
modulatory action observed on cortical 5-HT receptors (Agnati 
et al 1983). Gangliosides have also been shown to modulate 
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the phosphorylation system (Agnati et al 1984 1985; Bremer 
et al 1986) . 
Previous reports leveal that some organophosphate 
pesticides have been found to deplete the ganglioside 
concentrations in various CNS regions (Islam et al 1983, 
Tayyaba & Hasan 1985, Naqvi et al 1988, Khan & Hasan 1988), 
but the effects of dimecron have to date received little 
attention. 
1.8.0 Lipid Peroxidation: 
A recently applied approach to the study of 
neurotoxicology involves the investigation of lipid 
peroxidation (WHO 1986). The lipids within the membranes of 
cells from higher organisms contain large numbers of 
polyunsaturated fatty acid side-chains. Such fatty acids are 
prone to undergo a process known as "lipid peroxidation'. It 
is a basic detereorative reaction that is involved in many 
disease processes and cnemical toxicities (Tappel and Dillard 
1981). Recent interest in lipid peroxidation has probably 
resulted from the realisation that oxygen radicals do exist 
in biological tissues for an appreciable time (Tien et al 
1981). Lipid peroxidation in a process of direct reaction of 
oxygen with lipid to form free radical intermediates and 
hence creating semi-stable peroxides. Because of their 
unpaired electrons, free radicals react energetically and 
initiate relatively non-specific hydrogen abstraction and 
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chemical addition reactions. Major sites of lipid 
peroxidation are biomembranes and subcellular organelles 
(Tappel 1970). Lipid peroxidation "in vivo" has been found to 
be of basic importance in ageing, damage to cells by air 
pollution, toxic chemicals and in oxygen toxicity (Tappel 
1970). It has been found that loss of membrane integrity 
during pathological free radical mechanism leading to lipid 
peroxidation and degeneration of phospholipids are important 
factors which irreversiLily damage brain cells in ischaemic 
and other adverse conditions (Demopoulos et al 1979). The 
peroxidation of lipids can be highly catastrophic to the 
integrity of cellular membranes and to membrane bound enzymes 
(Bus and Gibson 1979). Kartha and Krishnamurthy (1978) 
reported that among the different tissues, the brain showed 
considerably high degree of peroxidation. Reaction of oxygen 
with lipids leads to a series of molecular rearrangements 
termed as peroxidation which results in a series of oxidative 
derivatives, including lipid peroxides, lipid hydroperoxides 
and aldehydes (Enterbaver 1982). Some of these are toxic to 
various cells, including endothelial cells (Sasaguri et al 
1984, Peng et al 1985). Dibiuption of lysosomal membranes by 
lipid peroxidation can spill hydrolytic enzymes into the rest 
of the cell and thus poteucidte the damage. 
Systemic study of the reaction kinetics of lipid 
peroxidation has shovm that the process is rather 
complicated (Vladimirov & Archakov 1972). The chemical 
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process of lipid peroxidti:ion (Mead 1976, Pryor et al 1976) 
is defined as the reaction of an oxidant initiator with a 
polyunsaturated fat (LH) to form a lipid-free radical 
intermediate (L*) leadiny to a peroxy free radical (LOO**) 
when it reacts with oxygen. A relatively non-specific 
hydrogen abstraction reaction is initiated when the unpaired 
electrons of the peroxy free radical react with another lipid 
molecule. 
—>• L 00" 
LOO** LH —» LOOH • L* 
The peroxy free radical can also react with an 
antioxidant to terminate the reaction chain. The 
administration of exogenous antioxidants not only inhibits 
lipid peroxidation but also restores the high level of thiols 
because of the lower concentration of hydroperoxides formed 
in the chain reaction. 
A mechanism for lipid peroxidation was proposed by 
Dahle et al (1962) which attempts to explain the following 
observations: the increase in absorbance at 233 nm at the 
early stage of oxidation, che appearance of lipid peroxides 
as intermediates in the t»^ -jc.i;ion, the inhibiting effect of 
chain-breaking antioxidant^ on the reaction, and the more 
facile production of malonaldialdehyde as quantified by the 
TBA test from linolenic or arachidonic acids when compared 
with linoleic acid. The steps in the oxidation of a diene or 
triene fatty acid systems are depicted in Fig.1.11. This free 
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radical chain reaction is initiated when some unidentified 
free radical abstracts a methylene H atom from the 
unsaturated fatty acid. The resulting free radical is 
stabilized by resonance, with several of the resonance forms 
adopting a conjugated diene system. Oxygen adds to the lipid 
free radical producing a hydroperoxy radical which may 
abstract a hydrogen atom from another unsaturated fatty acid, 
thereby propagating the chain reaction, to form a lipid 
peroxide. According to Dahle et al (1962) malonaldialdehyde 
is produced by the triene system, and not the diene system, 
because only with the triene is it possible to obtain the 
hydroperoxy radical with a double bond between the carbons B, 
r to the peroxy radical.. It is possible to obtain the cyclic 
peroxi'de II in triene systems which is the non-volatile 
precursor of malonaldialdehyde. Since both linoleic and 
linolenic acids can form II, then Dahle's mechanism does not 
explain the difference in the rate of malonaldialdehyde 
formation from linoleic and linolenic acids. Pryor et al 
(1976) suggest that the fatty acid free radical I abstracts 
a hydrogen atom internally. Triene systems produce a more 
stable bicyclic free radical III than diene systems since 
they are stabilized by the third double bond. 
0. /OH 
. ( I ) Q 2 I -^^C-CH'.: • O T H E R 
i i ) R ~ ' 0 — k J ^ h / ^OH ^ ^ ^ ^ ^ ^ ^ ^ 
1 
H O - 0 ( M A L O N A L D I A L D E H Y D E ) 
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The endoperoxide IV is the non-volatile malondialdehyde 
precursor in Pryor's mechanism. Pryor et al (1976) have also 
shown that many cyclic peroxides produced during the 
oxidation of unsaturated fatty acids give positive TBA tests. 
From this laboratoiy,. various studies have demonstrated 
alterations in the rate of lipid peroxidation in the CNS 
regions following expos'Jire to organophosphate pesticides 
(Islam et al 1983; Tayyaba & Hasan 1985; Hasan & Khan 1985; 
Vadhwa and Hasan 1986, Naqvi et al 1988), toxic gases and 
heavy metals (Haider L Hasan 1984, Bano and Hasan 1989, 
Farahani and Hasan 1990) and ageing (Gupta & Hasan 1988). No 
report, however, is available on the effect of dimecron on 
the brain lipid peroxidation. 
1.9.0 Glutathione-S-transferase 
Glutathione-S-tranaferases (GSTs) are a group of widely 
distributed (Grover and Sims 1964, Bend et al 1978, Mukhtar 
et al 1981) and multifunci;ional enzymes, which play a crucial 
role in the response of Cc^is to a vide variety of acute and 
chronic toxins (Patridqe et al 1983, Stockstill & Dauterman 
1982). Following types of bS'J's have been describe so far: 
(1) Glutathione-S-alkyI transferase, catalyzing the 
conjugation of a variety of alkyl halides with glutathione 
(Johnson 1966). 
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(2) Glutathione-S-epoxit!! transferase, active towards the 
conjugation of active epoxides with glutathione (Boyland & 
Williums 1965). 
(3) Glutathione-S-alkene transferase, catalyzing the 
conjugation of unsaturated compounds with glutathione. 
Glutathione (GSH) is a nucleophile involved in 
conjugation reactions which are important for elimination of 
foreign compounds in the body, such as electrophilic 
toxicants (Chasseaud 1980). The conjugates which are formed 
with GSH are more water soluble. GSTs are thought to play a 
physiological role in initiating the detoxification of 
potential alkylating reagents including toxicants and other 
pharmacologically active compounds (Boyland & Chasseaud 1969, 
Wood 1970). These enzymes catalize the reaction of such 
compounds with sulfhydryl (-SH) group of glutathione, thereby 
neutralizing their electrophilic sites and rendering the 
products more water soluble (Habig et al 1974) . Glutathione-
S-conjugates formed by G S t are further catabolized (Fig.1.12) 
to cysteine derivatives by simultaneous removal of glutamyl 
and glycine group by enzymes, r-glutamyl transferase and 
cystinyl glycinase respectively. S-conjugates are further 
acetylated by N-acetyl transferase to mercapturic acid 
(Boyland & Chasseaud 1969) . 
Jakoby and Keen (1977) have proposed that GST provides 
a 'triple treat' in the detoxification reactions: firstly, as 
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a catalysts in many reactions in which GSH acts as 
nucleophile, secondly as a storage facility for various 
compounds prior to their metabolism or excretion and thirdly 
as "sacrificial" covalent linkage for elcectrophilic 
compounds. 
Numerous compounds which can be detoxicated through GST 
include pesticides, food preservatives, food additives, 
carcinogens, polycyclic aromatic hydrocarbons, aminoazodyes 
(Boyland & Chasseaud 1969, Smith et al 1977). The currently 
available literature lacks any report regarding neurochemical 
effects of dimecron on the GST activity. 
1.10.0 Sulfhydryl Groups 
Sulfhydryl (-SH) groups play a pivotal role in many 
important enzymes by acting as active enzymatic sites (Hoch 
and Vallee 1959). Sulfhydryl groups derived from the side 
chains of cysteine residues, occur in a number of enzymes. 
There are two major types of -SH groups viz. protein-bound 
(PB) and non-protein bound (NPB). 
Sulfhydryl groups play an important role in GST-induced 
detoxification against electrophilic xenobiotics and 
toxicants by conjugating with such compounds and thus 
neutralizing their electrophilic sites (Habig et al 1974). 
NPB-SH has got a vital role in the cellular detoxification 
against free radical-mediated damage (Chio & Tappel 1969). 
Sulfhydryl enzymes have been found to be most susceptible to 
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lipid peroxidation-induced inactivation. Tappel (1970) has 
suggested that deficiency of total and free (NPB) -SH groups 
may lead to deficient degradation of lipid peroxides to 
hydroxy radicals, resulting in the accumulation of peroxides 
in various regions of the brain. The association of 
glutathione with lipid peroxidation is well recognized 
(Tappel and Dillard 1981). 
Sulfhydryl group of cysteine and the disulfide bond 
(-SS-) of cysteine are highly reactive and apparently 
involved in the maintenance of the conformation and 
biological activity of cc^_.ain proteins. As the receptors are 
protein in nature, the reagents which modify -SH groups may 
influence the interactions of neurotransmitters with their 
recognition sites (Sobrino & Del Castillo 1972, Barrantes 
1980) . 
Owing to the important role of -SH groups against the 
toxic compounds, it is relevant to evaluate the effect of 
organophosphate dimecron on the brain -SH contents. 
1.11.0 Superoxide dismutase 
Superoxide dismutase (SOD) is a very important enzyme 
which is essential fci IsC survival of aerobic cells. 
Superoxide radical (O;?-) a common intermediate of oxygen 
reduction. O2 is readilv, .;:-rcrated by so many spontaneous and 
enzymatic oxidations that they may be assumed to be produced 
within a n respiring vu^ aaisms (Misra & Fridovich 1972; 
67 
Heikkila & Cohen 1973, Maklund & Marklund 1974). Catalytic 
actions of several enzymes have been shown to evolve O2 
(McCord & Fridovich 1969, Massey et al 1969, Rajagopalan & 
Fridovich 1962, Rajagopalan & Handler 1964). Superoxide 
dismutase is the enzyme which catalytically scavenges the 
superoxide radical, which appears to be an important agent of 
the oxygen toxicity, and hence provides a natural defence 
mechanism against oxidative damage to the tissues (Fridovich 
1975) . The reaction whose rate it enhances is a 
disproportionation or dismutation of O2 radicals and may be 
expressed as: 
O2 + 02 + 2 H"^  H2 O2 + O2 
SOD is inducible by oxygen (Gregory & Fridovich 1973a, 
Gregory & Fridovich 1973b, Gregory et al 1974). This 
induction allows manipulation of the intracellular level of 
the enzymes by variation of the oxygen tension under which 
the cells are grown. Studies on both micro-organisms, as well 
as higher organisms, establish that SOD serves as an 
essential defense mechanism against oxygen and superoxide 
toxicity (Michelson & Buckingham 1974, Crapo & Tierney 1974) . 
SOD has been reported to prevent the swelling of rat liver 
mitochondria induced by glutathione. 
Organophosphates have been found to cause oxidative 
damage to the tissues thi, uuh lipid peroxidation (Tappel & 
Dillard 1981, Islam et al 1983; Tayyaba & Hasan 1985; 
Demopoulos et al 1979; Hasan & Khan 1985, Vadhva & Hasan 
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1986, Naqvi et al 1988). it is, therefore, possible that SOD 
might also play an important role in the organophosphate 
toxicity. No report, however, is available todate, on the 
effect of organophosphate pesticides on the SOD activity. 
1.12.0 Nucleic acids 
The discovery of the nucleic acids was the result of 
the work of Friedrich Miescher (1844-1895), the founder of 
our knowledge of the chemistry of the cell nucleus. In 1871 
he published a paper regarding the isolation of an acidic 
compound "nuclein" from the nuclei of the pus cells, which 
was readily soluble in dilute alkali but insoluble in dilute 
acid, and contained a hiqh proportion of phosphorus (Miescher 
1871). A number of scientists followed him, but only in 1930, 
a definite picture of tvo definite types of nucleic acids had 
emerged. One of them, the nucleic acid isolated from yeast, 
on hydrolysis yielded adenine, guanine, cystosine, uracil, 
phosphoric acid and a sugar (pentose), was identified by 
Levene and Jacobs (1909) as ribose. The other, the nucleic 
acid from thymus, yielded adenine, guanine, cytosine, 
thymine, phosphoric acid and a sugar (deoxypentose), was 
identified as deoxyribose (Levene et al 1930). The two 
nucleic acids, therefore, came to be called ribonucleic acid 
(RNA) and deoxyribonucleic acid (DNA), respectively. 
Initially, an assumption was made that DNAs were 
characteristics of animal tissues and RNAs, of plant tissues, 
but later on RNA was found to be present in animal tissue as 
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well (Jorpes 1934). 
In the brain, the nucleic acids provide for the storage 
and transmission of genetic information as well as 
information leading to the synthesis of cellular proteins 
(White et al 1978). 
A knowledge of DNA content helps in understanding the 
tissue components such as average cell densities, dry weight/ 
average cell and total number of cells in each brain area 
(May & Grenell 1959) . The only well-authenticated sites at 
which DNA is found in all animal cells, including the brain, 
are the nucleus (including nucleolus) and mitochondria 
(Mahler 1981). The DNA content of diploid mammalian cells, 
including neurons and other brain cells, is of the order of 
6.5 picograms per cell (or about 1 microgram per milligram of 
wet brain weight). This corresponds to a mass of 3.8 x 10^2 
daltons for the total chromosomal complement of such cells. 
Thus the maximal (haploid) content of genetic information 
available to these cells is about 800 times that of E. Coli, 
or 100 times that of yeast, encoded in 1.5 x 10^ base pairs. 
The amount of DNA in white matter approximately equals that 
in the cortex, and the regional differences in the content of 
brain DNA are relatively dinall (Logan et al 1952; Elliott & 
Heller 1957). Cerebellum, however, shows exceptionally high 
amounts of DNA (Grenell 1958, May & Grenell 1959). 
Deoxyribonuclease (DNase) is a highly specific 
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phosphodiesterase enzyme responsible for the hydrolytic 
degradation of DNA to mononucleotides and subsequently to 
nucleotides (Schmidt 1955). Neuronal nuclei prepared from 
young and adult rat brains have been shown to have a higher 
DNase activity than glial nuclei (Stanmbolova 1973). 
It has been reported that organophosphate, DDVP, 
induces degenerative changes in neurons and nerve fibres 
(Hasan et al 1979). The loss of myelin during degeneration 
and the subsequent myelination of the newly growing fibres 
bring about changes in most of the cell constituents 
including nucleic acids (Mcllwain & Bachelard 1971). 
Organophosphate metasystox i,as been reported to deplete the 
concentration of DNA in various brain regions, duly 
correlated with increasoi activity of DNase (Tayyaba et al 
1981) . 
In every cell not infected by an RNA virus, all RNA 
synthesis is absolutely dependent on the presence of a DNA 
template and is catalysed by a family of enzymes called DNA-
dependent RNA polymerases (Chambon 1974). Therefore RNA 
synthesis is expected to be localized at only two 
intracellular sites in all cells of the nervous system: in 
the nucleus, including the nucleolus, and in the mitochondria 
(Chambon 1978) . Most of the RNA of neurons is localized in 
the perikaryon, and there, as in all cells, the majority 
forms an integral constituent of ribonucleoprotein particles 
that are themselves ag- regated into polymeric structures. 
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These structures exist either free in cytosol or attached to 
membranes of endoplasmic reticulum. They are held together by 
messenger RNA (m RNA), and in conjunction with the soluble 
transfer RNA (tRNA) of cytosol, constitute the protein-
synthesizing machinery of the cell. In addition to their 
peikarya, certain neurons also may contain some RNA in their 
axons, including the presynaptic thickening. The axonal RNA 
may contribute some 0.5 mg per gram of wet weight (Koenig 
1969). The studies of RNA content helps to assess the rate of 
proJtein synthesis and also to evaluate the functional status 
of the nervous system (Bergen et al 1974). Edstrom (1956) and 
Edstrom and Pigon (1958) have suggested a proportionality 
between RNA content and the surface area of the cell body. It 
has been suggested that, in addition to the established role 
of nucleic acids in the biosynthesis of protein (Campbell 
1965), RNA and protein synthesis may be involved in the 
accrual of sensory information in the -brain, thus indicating 
a possible approach to elucidation of brain function on 
molecular basis (Hyden 1964) . 
Amount of RNA in gray matter usually exceeds that in 
white matter (Mihailovic et al 1958, Grenell 1958). RNA is 
highly concentrated in the nucleolus and in the Nissl 
substance of the cytoplasm of nerve cells (Landstrom et al 
1941; Hyden 1943). Ribonuclease (RNase), a highly specific 
phosphodiesterase enzyme, hydrolyzes all known RNAs by 
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catalyzing the cleavage of certain strictly defined 
internucleotide bonds (Schmidt 1955). 
It has been reported that RNA content was found to 
increase in the rat brain following metasystox toxicosis 
(Tayyaba et al 1981). It was demonstrated that RNA synthesis 
increases due to damage of the neurons, in which, RNA level 
remains high between 10 to 30 days after which it returns to 
normal level (Mcllwain & Bachelard 1971) . 
The available literature, however, lacks in any report 
on the neurochemical alterations in the metabolism of nucleic 
acids following dimecron toxicosis. 
1.13.0 Proteins 
Proteins are one of the many important biochemical 
components of the vertebrate brain. They constitute 40% of 
the dry weight and 8% of the wet weight of the fresh brain 
(Mcllwain & Bachelard 197'i). Proteins specific to the nervous 
system are of interest because they underline the 
developmental specialization and differentiation of the CNS 
cells. Some of the important nervous system specific proteins 
are S-100 protein, glial fibrillar protein, myelin proteins, 
postsynaptic density proteins, receptors for 
neurotransmitters, enzymes involved in catecholamine 
synthesis, etc. (Mahler 1981). The susceptibility of brain 
proteins, especially thoL>t. localized in the synaptic region 
and its membranes, to c-.valent modification may provide a 
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means for altering the efficacy of synaptic transmission as a 
function of neuronal activity. As the brain has high rate of 
metabolic activities, it needs more proteins for expected 
high rate of protein turnover. This view is well in agreement 
with the presence of large amount of cytoplasmic ribosomes 
which provide large number of sites for protein synthesis 
(Mcllwain & Bachelard 1971). 
The changes in the neuronal activity are found to be 
accompanied by perturbations in macromolecules like protein 
in the brain cells. Incieased neuronal activity has been 
reported to inhibit the protein synthesis (Hyden and Lange 
1972). The specific neuronal functions such as conduction of 
action potentials and synaptic transmission are extensively 
mediated by proteins (Bock 1978). Proteins in the brain are 
in a dynamic steady state. Protein synthesis probably starts 
from free amino acids, which are activated and transferred to 
a soluble ribonucleic acid or nucleoprotein (Mahler 1981). 
Proteins destined for intracellular use are synthesized by 
polysomal arrays in the cytosol, that are unattached to 
membranes. Proteins destined for export from the cell of 
origin as well as those t-^sma membrane proteins that will 
become part of its exL^rnal aspect, are synthesized by 
polysomes attached to the lu.mbranes of endoplasmic reticulum. 
Protein contents have been found to diminish in various 
CNS region following intoxication by phosalone (Tamilvanan 
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1984), metasystox (Tayvaba et al 1981), methyl parathion 
(Khan 1989) and dichloivos (Vadhva 1989). To date, however, 
dimecron has not been reported to induce changes in the 
protein metabolism. 
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2.14.0 AIMS OF THE PRESENT STUDY 
Main aims of the present investigation were as follows; 
(1) To study quantitative alterations in the following 
neurochemical parameters in various CNS regions of dimecron-
intoxicated rats: 
- Acetylcholinesterase activity 
- Concentration of monoamines 
- Monoamine oxidase activity 
- Concentration of •otal lipids, phospholipids, 
cholestero] and gangliosides 
- Rate of lipid peroxidation 
- Content of sulfhydiyl groups 
- Activity of glutathione-S-transferase 
- Activity of superoxide dismutase 
- Level of nucleic acids and total protein 
(2) To evaluate dimecroi ~ induced perturbation in the Open 
Field Behaviour of the 1 : ..-dted rats, and to correlate them 
with the alterations in the monoamine metabolism. 
(3) To determine the quantity of the diniecron accumulated in 
different regions of the CNS following graded dosing of 
dimecron, and to find out possible correlation between 
accumulated dimecron content with its neurotoxicity. 
(4) To investigate the possible protective effect of 
antioxidant, acetylhomocystein thiolactone against the 
neurotoxic effects of dimecron. 
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2. MA. iiitlAL AND METHODS 
2.1 Animals: 
Male albino rats of Charles Foster strain, weighing 150 
+ 20 g, were obtained from the Central Animal House of J.N. 
Medical College, A.M.U., Aligarh. They were fed commercial 
diet (Hindustan Lever Laboratory, Bombay) and water ad 
libitum and maintained in normal laboratory conditions with a 
light-dark cycle of 12:12 hrs. 
2.2 Drugs used: 
1. Dimecron: Dimecron (2-chloro-2-diethylcarbamoyl-l-
methylvinyl dimethyl phosphate), commonly known as 
phosphamidon, was procured from Hindustan CIBA-GEIGY Ltd, 
Bombay. Intraperitoneal LD5Q of dimecron for rats has been 
reported to be 5.8 mg/kg (Menzer and Best 1968). 
2. Cithiolone: Cithiolone (DL-N-acetylhomocysteine 
thiolactone) was purchased from Aldrich Chemical Company Inc, 
USA, 
2.3 Experimental Design: 
Animals were broadly divided into four groups. To 
animals of the first group, serving as experimentals, freshly 
prepared dose of dimecron (2.0 mg/kg b. wt) was administered 
intraperitoneally (ip) daily for seven days. The dose was 
prepared by dissolving 0.023 ml of commerical dimecron (85% 
v/v) in 10 ml physiological saline (0.9% sodium chloride). 
The second group served its 'control' and was given equal 
volume of saline (ip) concurrently. The third and fourth 
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Fig. 2.2 Photograph of dissected rat brain (Dorsal view) 
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groups were used in the studies related to the protective 
effects of cithiolone against dimecron neurotoxicity. Animals 
of the third group received cithiolone (8.0 mg/Kg, b.wt, ip. 
alone), while the fourth group was administered dimecron (2.0 
mg/Kg b. wt, ip) and cithiolone (8.0 mg/Kg b. wt, ip) 
concomitantly for seven days. The dose of cithiolone, chosen 
after Totaro et al (1968), was prepared by dissolving 80 mg 
commercial cithiolone (99%) in 10 ml physiological saline. 
[A] BEHAVIORAL STUDIES 
2.4 Open Field Behaviour 
2.4.1 Apparatus: The apparatus used in the open field 
behaviour (OFB) test was similar to that used by Holland and 
Gupta (1966). Briefly, it consisted of a wooden, circular 
open arena (82 cm diameter) surrounded by a wall 31 cm high. 
The wooden floor was marked with three centric circles which 
were divided into segments by lined radiating from the 
centre. These 25 units of approximately equal size were used 
to score ambulation of the uwimals during the test. Two types 
of stimuli were presentee' tu the animals: white noise (78 dB, 
Ref. Intensity 0.0002 dyn/ci-n^) was produced by an oscilator 
through four loudspeaker;..; and light (165 footcandles) was 
presented by four lamps. A Icanslucent glass screen enclosed 
the arena on all sides, the front side having a glass door 
through which the animals v/ere placed in the arena. 
2.4.2 Procedure: After one hour of injections, each animal of 
both the experimental and control groups was exposed daily 
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for two minutes in t'-e open field chamber, and the 
ambulation, rearing and preening responses were recorded by a 
three-channelled hand-opsrated counter. The ambulation score 
was defined as the walking score derived from the number of 
radial segments crossed by the animals. The placement of all 
the four limbs in one segment was taken as one unit of 
ambulation. A rearing rocre of 1 was awarded when the rat 
stood on its hind limbs with the support of the wall, and 2 
for standing without support. Preening response was 
determined by the number of times the animal scratched its 
face with the forelimbs. 
[B] BICCHEMICAL STUDIES 
2.5 Dissection and Isolation of Different CNS Parts: 
Overnight fasted rats were scarificed on the seventh 
day of injection, by cervical disolocation followed by 
decapitation. Brains were removed quickly and the cerebrum, 
cerebellum, brain stern and spinal cord were dissected out 
rapidly on ice-plate. Different CNS regions were then cleaned 
with normal saline to remove the blood clottings, and weighed 
accurately to the nearest milligram. 
2.6 Assay of Acetylcholinesterase 
The activity of -etylcholinesterase (AChE) was 
measured by the method r'llman et al (1961). 
The principle of ~ method is the measurement of the 
rate of production of thio^noline as AChE is hydrolysed. This 
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is accompanied by the concinuous reaction of the thiol with 
5,5-dithiobis-2-nitrobenzoate ion to produce the yellow anion 
of 5-thio-2-nitrobenzoic acid. 
2.6.1 Chemicals and Reagents: 
1. Phosphate buffer (0.1 M, pH 8.0) 
2. DTNB Reagent: 39.6 mg of 5,5'-dithiobis-2-nitrobenzoic 
acid (DTNB) was dissolved in 10 ml of 0.1 M phosphate 
buffer (pH 8.0), and 15 mg of soidum bicarbonate was 
added to it. 
3. Substrate: 0.075 M acetylthiocholine iodine (Sigma, USA), 
4. Inhibitor: 10"^ M eserine sulphate (Sigma, USA) was 
dissolved in 0.1 M phosphate buffer (pH 8.0). 
2.6.2 Procedure: Saline cleaned and accurately weighed tissue 
were homogenized in 0.1 M phosphate buffer (pH 8.0) in a 
concentration of 10 mg/ml and centrifuged at 1,500 rpm for 5 
min. 0.4 ml of supei idtant was pipetted in a cuvette 
containing 2.6 ml of phosphate buffer. To this, 0.1 ml of 
DTNB reagent was added aiid mixed well. The cuvette was placed 
in a Beckman DU-6 spectrophotometer and the absorbance at 412 
nm of the suspension vas set to zero. 0.02 ml of the 
substrate was added ar^ -? ^ changes in the absorbance were 
recorded from 5th to lOti .i.,.n at the interval of one minute. 
To determine non-spe' esterase, 0.1 ml of eserine 
sulphate was added to a'._ther cuvette containing 0.4 ml of 
homogenate supernatant, 2.5 ml of phosphate buffer and 0.1 ml 
DTNB reagent. The changes in absorbance were recorded as 
described earlier, aftei adding 0.02 ml of substrate. The 
rate of change of activity of the suspension with eserine was 
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substracted from that of the suspension without eserine. The 
enzyme activity is expressed as /O. moles of substrate 
hydrolysed per g tissue per minute. 
Calculation: 
A 1 A R = X = 5.74 (10)-4 — 
1.36(10'^) (400/3120)Co Co 
where, R= Rate of enzyme acitivity in moles of substrate 
hydrolysed/g tissue/ min 
A = Change in absorbance per minute 
Co = Original concentration of tissue (mg/ml) 
2.7 Determination of Monoariiies 
Monoamines, dopamine (DA), norepinephrine (NE) and 
serotonin (5-HT) were extracted and estimated according to 
the method of Welch and Welch (1969). 
2.7.1 Chemicals and Reagents? 
1. n-Heptane: Analytica3 Grade 
2. n-Butanol: AnalyticaJ Grade 
3. Peroxide free ethei- Diethyl ether was washed with 
saturated solution ferrous sulphate to remove 
accumulated peroxidvTO. Thereafter, washed with double 
distilled water (DDW) ^o remove the excess of sulphate. 
4. Ethylenediamine 
5. Acetate Buffer (2 pH 6.8): 2M acetic acid was 
adjusted to pH 6.8 with 2N sodium hydroxide. 
6. Phosphate Buffer (0,5 M, pH 7.3); 77 ml of 0.5 M 
monobasic sodium phoaphdte was mixed with 23 ml of 0.5 M 
dibasic sodium phosphate. 
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7. Sodium thiosulphate (O.lN): 1.581 g of sodium 
thiosulphate (Na2 S2O3.5H2O) was dissolved in 100 ml 
DDW. 
8. EDTA solution (10%): 10 g of ethylenediaminetetraacetic 
aid (EDTA) was dissolved in 100 ml DDW. 
9. Alkaline sulphite-EDTA solution: 12.6 g sodium sulphite 
was dissolved in 100 ml 10% EDTA solution and diluted to 
250 ml with 5N NaOH. 
10. Alkaline Ascorbic acid-Ethylenediamine solution: 200 mg 
of ascorbic acid was dissolved in 25 ml of 0.01 N HCl 
and added to a mixture of 0.5 ml ethylenediamine and 
22.5 ml of 10 N NaOH. This was thoroughly mixed by 
shaking. This reagent was freshly prepared immediately 
before use. 
11. Iodine solution; 3.175 g iodine together with 12.5 g of 
sodium iodine were dissolved in 250 ml of DDW, and 
stored in a dark-colouicd bottle in cold. 
12. Stock solutions: The solutions of dopamine, 
norepinephrine and serotonin were prepared in 0.01 N HCl 
at a concentration of 100 AJg/ml and stored in 
refrigerator. 
13. Standard solutions: On Lhe day of experiment, the stock 
solutions were dilutcu ,.'ith 0.01 N HCl to get working 
standard solutions cortesponding to 100 ng/ml of NE and 
200 ng/ml of DA and 5-HT. 
2.7.2 Extraction Procedure: The brain parts were homogenized 
in 1.5 ml ice-cold 0.01 N ilCl. 0.1 ml of 10% EDTA was added to 
the homogenate and then transferred to glass-stoppered bottles 
containing 2.5 ml of n-butanol and 2 g of NaCl. The bottles 
were shaken for 10 min and centrifuged at 3,000 rpm for 10 
min. in cold. The butanol layer was separated, transferred to 
another set of glass-stoppered botles each containing 20 ml 
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n-heptane and then added 1.5 ml phosphate buffer. The 
mixture was shaken for 10 inin and centrifuged in cold, 
keeping pH not below 7. The phosphate buffer (1.5 ml) was 
drawn from butanol phase and transferred to another bottle 
and pH was adjusted to 3.5-4 using 3N HCl. Thereafter, 10 ml 
of peroxide free ether was added and bottles were shaken well 
and centrifuged in cold. The acidic aquous layer was taken 
from bottom with 0.5 ml micropipette and three 0.5 ml 
aliquots were collected separately for the determination of 
DA, NE and 5-HT respectively. 
2.7.3 Analysis of Monoamines; The samples of monoamines 
obtained after extraction, were analysed using RF-40 
spectrofluorometer Shimadzu, Japan according to the following 
procedures: 
2.7.3.1 5-HT: The sample (0.5 ml) was mixed with 0.5 ml 6N 
HCl and the native fluorescence was immediately read at 
295/535 nm using 5 mm slit- Thereafter these tubes were used 
as blanks for DA analysis. 
2.7.3.2 Norepinephrine: Tr i^ ach 0.5 ml extract, 0.5 ml 2 M 
acetate buffer, 0.1 ml iodi ne solution, 0.15 ml 0.1 N sodium 
thiosulphate and 0.2 ir.i alkaline ascorbic acid-
ethylenediamine mixture were added in respective order, 
thereby making a total volume of 1.45 ml. Each reagent was 
added after an interval of 5 min and the viscous mixture was 
thoroughly mixed by shaking The fluorescence was recorded at 
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400/510 nni using 2 or 3 im.. slit. 
2.7.3.3 Dopamine: 0.5 ml extract was mixed at 5 min intervals 
with 0.5 ml 2 M acetate buffer, 0.1 ml iodine solution, 0.2 
ml alkaline sodium sulphite-EDTA solution and 0.25 ml 1:1 
glacial acetic acid-HCl mixture, respectively to make a final 
volume o 1.5 ml. The tubes were placed in boiling water bath 
for 45 min and then allowed to cool at room temperature. 
Fluorescence was read within 1-2 hr at 335/380 nm using 2 mm 
slit. 
2.7.4 Preparation of standard curves: The standard curves for 
DA, NE and 5-HT were prepared by analysing fluorometrically 
(as described in "Analysi£> of Monoamines"), the standard 
amine solutions in the ramji of 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 
0.7. ml corresponding to 10, 20. 30, 40, 50, 60, 70 ng of NE 
and 20, 40, 60, 80, 100, 120, 140 ng of each of DA and 5-HT. 
2.8 Assay of Monoamine Oxidase 
The activity of luoi.oamine oxidase (MAO) was assayed 
following spectrophotometric method of Tabor et al (1953) . 
The benzylamine undergoes oxidative deamination in the 
presence of MAO leading to formation of benzaldehyde. 
2.8.1 Chemicals and Reagents: 
1. 0.5 M Phosphate Buffer (pH 7.2) 
2. Perchloric acid, 10% (Analytical Grade) 
3. Substrate: 0.1 M benzylajiune hydrochloride 
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2.8.2 Procedure: 
The reaction mixture in a final volume of 2 ml 
consisted of 0.4 ml 0.5 M phosphate buffer (pH 7.2), 0.1 ml 
of 0.1 M benzylamine hydrochloride and 0.2 ml of brain 
homogenate (10% w/v in phosphate buffer). The reaction 
mixture was incubated at 37°C for 30 min. The protein was 
precipitated by centrifuging at 2,500 rpm for 10 min. The 
optical density (OD) of benzaldehyde formed was read in the 
supernatant at 250 urn on Beckman DU-6 UV/VIS 
spectrophotometer against blank treated similar to samples, 
containing 0.2 ml of 0.44 M socrose instead of the brain 
homogenate. 
15.385 X OD 
Calculation: Activity of MAO = 
Protein conc. 
Where OD = Change in OD per minute 
The enzyme activity is expressed as n moles of 
benzaldehyde formed/ min/ mg protein. Protein was estimated 
by the method of Lowry et al (1951). 
2.9 Brain Lipids 
2.9.1 Extraction of Lipids from Discrete Brain Areas: 
Different parts of the brain (50-200 mg) were 
homogenized in a glass hoji._9..aizer to a final volume of 6 ml 
chloroform - methanol (2:1, v/v) according to the method of 
Folch et al. (1951). Each homogenate was shaken periodically 
for an hour and filtered thiough sintered glass funnel (G-4) 
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under vacuum. The residue of each test tube was again 
homogenized with 2 ml chloroform-methanol and filtered. The 
test tubes were rinsed with fresh chloroforrn-methanol and 
again filtered. The fina] volume of each extract was made 
upto 10 ml with fresh chloroform-methanol mixture. Thereafter 
2.5 ml of normal saline solution was added to the extract in 
each test tube (4:1, v/v). This was shaken vigorously on 
cyclo-mixer for complete mixing, and placed at -20°C in a 
deep freeze overnight for complete separation of the two 
layers. The junction of the two layer in each test tube was 
marked. The upper layer was used for the estimation of 
gangliosides. The lower layer was collected in stoppered 
tubes with the help of a syringe and stored at -20OC until 
final use. The test tubes in which the two layers were 
separated, were dried and the volume of the lower layer in 
each test tube was measured. This extract was used for the 
estimation of total lipids, phospholipids and cholesterol. 
2.9.2 Estimation of Total Lipids: 
Total lipids were estimated according to the method of 
Woodman and Price (1972), described as follows: 
2.9.2.1 Chemicals and Re^otnts 
1. Standard Solution: Standard solution of 0.5 mg brain 
lipids/ml of chlorcf.rm-methanol (2:1) was prepared by 
diluting 1.0 ml refrijerated stock solution (50 mg brain 
lipid/10 ml chloroform-methanol) in a 10 ml standard 
flask and made up the volume to 10.0 ml with chloroform-
methanol (2:1, v/v). 
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2. Coloring Reagent: 6,0 g potassium dihydrogen 
orthophosphate and :.3 g vanillin were dissolved by 
heating in a 100 ml volumetric flask and the volume was 
made upto 100.0 ml wicn double distilled water (DDW). 
3. Cone. Sulfuric acid, A.R. 
4. Brain Lipids: Lipids were isolated from the rat brain by 
the technique as described in the Extraction in Brain 
Lipids. The extract was dried by vacuum rotatory 
evaporator at 40OC and dried lipids were stored at 
O-S^c. 
2.9.2.2 Procedure: 0.1 ml of duplicate brain extracts and a 
duplicate set of standard with 50 to 500 /u g of brain lipids 
were taken in 18 x 150 mm Corning test tubes. To this was 
added 2.5 ml conc. sulfuric acid and heated in boiling water 
bath for 20 min. After cooling, 5.0 ml coloring reagent was 
added and absorption was read at 530 nm exactly after 10 min 
against a reagent blank on a Beckman DU-6 spectrophotometer. 
Calculation: 
C X V 
Total lipids (mg/g fresh weight) = 
Vt X Wt 
where C = Concentration of lipids in g in 0.1 ml brain 
extract 
V = Total volume of lower layer 
Vt = Volume taken for estimation 
Wt = Fresh weight of the tissue in mg. 
The above formula was used also for calculating the 
concentrations of phosphoJipids and cholesterol. 
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2.9.3 Estimation of Phospholipids: 
Phosphate of the phospholipids was estimated by the 
method of Fiske and Subbatow, as described by Marinetti et 
a]. (1962). 
2.9.3.1 Chemicals and Reagents: 
1. A standard of 0.01 nig inorganic phosphate/ml was 
prepared by diluting 5.0 ml refrigerated stock solution 
(0.439 g KH2 PO4/5OO ml DDW) in a 100 ml standard flask 
with DDW. 
2. Perchloric acid 70% A.R. 
3. Aitmionium molybdate solution 2.5%. 
4. Reducing Reagent: Reducing reagent was prepared by 
dissolving 3.0 g sodium bisulphite, 0.6 g sodium 
sulphite and 0.05 g recrystalysed l-amino-2-naphthol-4-
sulphonic acid (ANSA) in 25 ml DDW. A slight yellow 
solution thus obtained was stored in amber coloured 
bottle. The colour is stable for a week at the room 
temperature. 
5. Recrystalization of ANSA: 15.0 g soidum metabisulphite, 
1.0 g sodium sulphite (anhydrous) and 1.5 g crude ANSA 
were dissolved in 100 ml DDW by heating on the boiling 
water bath. Hot solution was filtered through the filter 
paper, 1.0 ml conc. HCl was added in the filterate and 
stirred. Frecipitable was filtered wiht suction pump and 
washed with about 30 ml double distilled water and 
finally with alcohol ti'i washing is colourless. This 
purified ANSA was dried in oven at lOO^C for 1 hr with 
least possible exposure to light and was transfered to 
amber coloured bottle. 
2.9.3.2 Procedure: 0.2 ml of duplicate brain lipid extract 
(Lower layer) was placed in 18 x 150 mm Corning test tubes 
and all the solvent was dried up by heating on a
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water bath. Added 1.0 ml AR grade 70% perchloric acid to the 
samples and heated on a digester for 30 min or until the 
sample became clear. After complete digestion samples were 
cooled to room temperature. Thereafter, 1.5 ml ammonium 
molybdate, 0.2 ml reducing reagent and 7.0 ml DDW were added 
with vigorous shaking after each addition. The test tubes 
were heated on boiling water bath for 7 min. After 30 min. 
the colour intensity was read at 700 nm. A calibration curve 
was prepared with 1 iUg to 8/jg of phosphorous and 1.0 ml 
perchloric acid. Blank was prepared with 1.0 ml perchloric 
acid alone. 
Calculation: The absorption is a linear function of the 
phosphorus content and the amount in unknown sample can be 
calculated by direct proportion with the absorbance obtained 
for the standard. The amount of the phospholipid was 
calculated by multiplying with a factor of 25. 
2.9.4 Estimation of Cholescerol 
Total cholesterol was estimated according to the method 
of Henly (1957), slightly modified in accordance with our 
laboratory conditions. 
2.9.4.1 Chemicals and Reagents: 
1. Standard Solution: For Stock standard solution, 10 mg 
cholesterol (BDH) was dissolved in 10 ml chloroform. The 
working standard was prepared by diluting 1.0 ml of the 
stock solution to 25 ml chloroform, so that 1 ml of this 
solution contains 0.04 mg cholesterol. 
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2. Ferric chloride-acetic acid solution: 0.25 g FeCl3.6H20 
(ferric chloride) was dissolved in 500 ml glacial 
acetic acid. 
3. Glacial acetic acid: Analytical Grade. 
4. Cone. Sulphuric acid: Analytical Grade. 
2.9.4.2 Procedure: Brain extract (0.05 ml) was taken in 18 x 
150 mm test tubes and placed in boiling water bath until the 
solvent was completely evaporated. After cooling it down to 
room temperature, 6.0 ml of ferric chloride solution was 
added and centrifuged at 3,000 rpm for 10 min. Supernatant 
was drawn out and 5.0 ml of it was heated on boiling water 
bath for one minute and cooled at room temperature. 
Thereafter, 5.0 ml of conc. sulphuric acid was added to each 
test tube and mixed at once. Exactly after 10 min, the 
absorbance was read at 560 nm. The standard set was run 
similarly as described above, and the calibration curve was 
plotted by least square method. 
The concentration of cholesterol was expressed as mg 
per gramme of fresh tissue. 
2.9.5 Estimation of Gangliosldes: 
Gangliosides were estimated according to the method of 
Pollet et al. (1978), as follows: 
2.9.5.1 Chemicals and Reagents: 
1. Standard solution: A standard solution of 100 M g N-
acetyl neuraminic acid (Sigma Chem., USA) / ml DDW was 
made by diluting 1.0 ml of the refrigerated stock 
92 
solution (10.0 mg N-acetyl neuraminic acid dissolved in 
10 ml DDW) to the final volume of 10.0 ml with DDW. 
2. Resorcinol Reagent: It was prepared by mixing 10.0 ml of 
3% resorcinol solution in DDW, 80 ml conc. HCl, 0.25 ml 
0.1 M copper sulfate and DDW upto 100 ml. 
2.9.5.2 Procedure: To 2.0 ml of the upper layer of the lipid 
extract, 2.0 ml of resorcinol solution was added. The test 
tubes were heated on boiling water bath for 30 min. After 
cooling, 5.0 ml of a mixture of n-butyl acetate-n-butanol 
(85:15, v/v) was added to each tube. The tubes were shaken 
thoroughly and kept for 15 min to separate the organic phase. 
About 3-4 ml of the organic phase was taken and absorbance 
was measured at 580 nm against a reagent blank. A standard 
curve with different concentrations of N-acetyl neuraminic 
acid (5-30 Aig) having 2.0 ml final volume of DDW was 
prepared by the similar procedure. 
Calcualtion: 
C X V 
Ganglioside (mg/g fresh wt ) = 
Vt X Wt 
where C = Concentration in g in 2.0 ml extract 
V = Total volume of the upper layer 
Vt = Volume taken for .^he estimation 
Wt = Fresh weight of r^  3 tissue in mg. 
2.10 Determination of RaL^ of Lipid Peroxidation: 
The amount of malonaldialdehyde formed / 30 min during 
lipid peroxidation was estimated according to the procedure 
of Utley et al. (1967), as described below: 
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2.10.1 Chemicals and Reagents: 
1. 0.15 M Potassium chloride: 2.2368 g KCl dissolved in 200 
ml DDW. 
2. 10% (w/v) Trichloroacetic acid: 10.0 g TCA dissolved in 
100 ml DDW. 
3. 0.67% 2-thiobarbituric acid (TBA): This was prepared by 
dissolving 0.67 g TBA in 25-50 ml DDW by adding two 
pellets of NaOH. The pH of the solution was adjusted to 
7.2 with the help of IN HCl and the volume was made 
upto 100 ml with DDW. 
2.10.2 Procedure: Different parts of the brain were 
homogenized (10%, w/v) in chilled 0.15 M KCl. One of each 
homogenate was taken in a 25 ml conical flask and incubated 
at 37 ± 1<^ C in a metabolic shaker (120 strokes / min; 
amplitude 1 cm) for 2 hours. Thereafter, 1.0 ml of the same 
homogenate was pipetted in centrifige tubes and protein was 
precipitated by adding 1.0 ml of 10% TCA. After incubation, 
1.0 ml of 10% TCA was added to each sample and both the 
incubated as well as non-incuhated samples were centrifued at 
3000 rpm for 10 min. One ml of the clear supernatent was 
mixed with 1.0 ml of 0.67% TBA and 1.0 ml DDW and the tubes 
were placed in a boiling v.ater bath for 10 min, cooled and 
the absorbance of the colour was measured at 535 nm. 
Calculation: 
Lipid peroxidation was calculated using the following 
formula: 
OD X 30 X 1000 X 1000 X 1000 x 3 x 2 
X = 
1.56 X 100000 X 1000 x 180 
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OD X 10 
1.56 
where X = nanomoles of roalonaldialdehyde formed / 30 min. 
OD = Change of optical density at zero hr and 2 hr 
incubation of the same sample. 
2.11 Sulfhydryl (-SH) Groups: 
Sulfhydryl groups were estimated following the method 
of Sedlak and Lindsay (1968). 
2.11.1 Chemicals and Reagents: 
1. 0.15 M KC] 
2. Methanol: Analytical Grade 
3. Tris-EDTA buffer (pH 8.2): 0.2 M tris (2.423 g) and 0.2 
M EDTA (0.744 g) were dissolved in 80 ml DDW, pH was 
adjusted to 8.2 and the volume was made up to 100 ml 
with DDW. 
4. Tris-EDTA buffer (pH 8.9): 0.4 M tris (4.846 g) and 0.02 
M EDTA (0.744 g) were dissolved in 80 ml DDW, pH 
adjusted to 8.9 and the volume was made up to 100 ml 
with DDW. 
5. Dithiobis-2-nitrobenzo.i(.: acid (DTNB) , 0.01 M: 99 mg DTNB 
was dissolved in 25 ml methanol. 
6. Trichloroacetic acid (TCA): Analytical Grade 
7. Standard: Glutathione (reduced) 
2.11.2 Procedure: 
2.11.2.1 Total -SH: 0.1 ml of the brain homogenate (10% w/v, 
in chilled 0.15 M KCl) was mixed with 1.5 ml Tris-EDTA (pH 
8.2) and 0.1 ml DTNB solution. After shaking well, 8.3 ml 
methanol was added and the uDes v^ ere centrifuged at 6000 rpm 
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in cold for 5 min. The supernatant was drawn and the yellow 
colour was read at 412 nm on Beckinan DU-6 spectrophotometer 
within 30 min. 
2.11.2.2 Non-Protein bound (free) -SB: One ml of the brain 
honiogenate (10% w/v/ in chilled 0.15 M KCl) was mixed with 1 
ml 10% TCA and centrifuged at 6000 rpm for 15 min. From the 
supernatant, 0.5 ml aliquot was taken and 0.5 ml DDW was 
added to it. This was mixed with 2.0 ml Tris-EDTA buffer (pH 
8.9) and 0.1 ml DTNB solution, and shaken well. The 
absorbance of the yellow colour was recorded at 412 nm within 
30 min. 
2.11.2.3, Protein bound -Sfl: Protein bound sulfhydryl groups 
were determined by substracting free -SH from total -SH, 
as described by Sedlak and Lindsay (1968). 
2.12 Glutathione-S-transferase: 
The mitochondrial enzyme, glutathione-S-transferase 
(GST) was assayed by the nieuh. of Habig et al (1974) . 
2.12.1 Chemicals and Reagents 
1. 0.2 M Phosphate buffer (pH 6.5): 6.8 ml of 0.2 M 
solution of monobasic sodium phosphate was mixed with 
31.5 ml of 0.2 M solution of dibasic sodium phosphate, 
pH was adjusted to 6.5 and diluted to a total of 200 ml 
with DDW. 
2. 1 mM Glutathione: 30 mg of glutathione (reduced) was 
dissolved in 100 ml of phosphate buffer (pH 6.5). 
3. Substrate: ImM CDNB was prepared by dissolving 30 mg of 
CDNB (l-chloro-2, 4-dinitrobenzene) in 1 ml acetone. 
4. Acetone: Analytical Grade 
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2.12.2 Isolation of Post-Mitocbondrial Fraction (PMF): 
Different regions of the CNS were homogenized in chilled 
phosphate buffer (10% w/v) and centrifuged in cool for 15 min 
at 15000 rpm. 
2.12.3 Assay of GST: In 0.1 ml of post-mitochondrial fraction 
(supernatant), 2.7 ml cjl utathione solution and 0.2 ml 
substrate were mixed. The optical density (OD) was recorded 
at 340 nm against blank at every 15 sec for 3 min. The blank 
contained 0.1 ml DDW in plucv.* of PMF. 
Calculation: 
OD X 625 (factor) 
GST Activity = units/mg protein 
Protein conc. (mg) 
where OD = change of OD i-er minute 
2.12.4 Activity units: A unit of activity is defined as the 
amount of enzyine catalyzing the formation of 1 mole of CDNB 
conjugate per minute under specific assay conditions. 
Specific activity is defined as the units of enzyme activity 
per mg of protein, as measured by the method of Lowry et al 
(1951), with bovine serum cilbumin as standard. 
2.13 Superoxide disnutast^ t 
Superoxide dismutat^ (SOD) activity was measured 
following the procedure of Marklund & Manrklund (1974). 
The principle of the procedure depends upon 
autoxidation of pyrogallo.l . 
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autox idation 
Pyrogallol h O2 > Oxidation product + O2 
SOD 
2 O2 + 2 H+ > O2 + H2 O2 
2.13.1 Chemicals and Reagents: 
1. 0.05 M Tris-Succinate buffer (pH 8.2): Dissolve 606 mg 
Tris in approx. 60 ml DDW. To this, 39.3 mg EDTA was 
added and the pH wai adjusted to 8.2 with succinic acid 
solution. The volurr.f was then made up to 100 ml with 
DDW. 
2. Succinic acid solution, 0.05 M: 590 mg succinic acid was 
dissolved in 100 ml JDW. 
3. Pyrogallol solution, 8 mM: 100 mg pyrogallol was 
dissolved in 100 rr.l DDW. This solution was prepared 
fresh on the day of experiment. 
2.13.2 Procedure: Different saline cleaned CNS parts were 
homogenized (10% w/v) in chilled 0.15 M KCl and centrifuged 
in cool at 10,000 rpm for 15 min. The supernatant was used as 
sample solution. 0.05 ml of the sample solution was added to 
2.85 ml tris-succinate buffer, mixed well and incubated at 
25<^ C for 20 min. The reacLion was started by adding 0.1 ml 
pyrogallol solution. The c iitents were shaken well and change 
in absorbance per min was immediately recorded for 3 minutes 
at 420 nm on Beckman JU-6 UV/vis spectrophotometer. A 
reference set, consisting of 0.05 ml DDW instead of the 
sample solution, was also lun similarly. 
Calculation: 
A/min^ef " A/min sample) x 30 
SOD Activity units/10 mg 
A/minj-ef // 0.05 x 1 tissue 
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where A/min^ef = change of absorbance per min in reference 
set 
A/minsaif,p2e = change of absorbance per min in sample 
2.13.3 Activity Unit: One unit of the enzyme is defined as 
the amount of enzyme which causes a 50% inhibition of 
pyrogallo] autoxidation under assay conditions. 
2.14 Nucleic Acids 
2.14.1 Isolation of Nucleic Acids: 
Nucleic acids were isolated following the method of 
Searchy and Maclnnis (1970). Weighed tissue of the different 
CNS regions were homogenized in 5.0 ml of 0.5 N perchloric 
acid. The homogenate was heated at 90°C in boiling water bath 
for 10 min, cooled and centrifuged at 3,000 rpm for 10 min. 
The suf^ernatant was taken in graduated test tubes and the 
volume was maintained up^ to "5.0 ml with 0.5 N perchloric acid. 
This extract was then used '.n the estimation of DNA and RNA 
according to the following ,i:ocedures. 
2.14.2 Estimation of DNA: 
DNA was estimated following the method of Burton 
(1956) . 
2.14.2.1 Chemicals and Reagents: 
1. Diphenylamine Reagent,- J.5 g diphenylamine was dissolved 
in about 50-60 ml glacial acetic acid. 1.5 ml conc, 
H2SO4 was added to it and the final volume was 
maintained upton 100 ml. 
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2.14.2.2 Procedure: 2.0 ml of the supernatant of nucleic acid 
extract was taken in a test tube. To this, 4.0 ml 
diphenylamine reagent was added, and the tubes were heated on 
boiling water bath for 15 min. After cooling, the colour 
intensity was measured at 600 nm against a reagent blank. 
2.14.3 Estimation of RNA: 
RNA was estimated of Dische (1955). 
2.14.3.1 Chemicals and Reagents: 
1. Oricinol Reagent: 33.0 mg ferric chloride was dissolved 
in about 50 ml conc. HCl, 3.5 ml 6% orcinol (dissolved 
in absolute alcohol) was mixed with it, and the volume 
was made upto 100 ml with HCl. 
2.14.3.2 Procedure: 2.0 ml of the supernatant was taken in 
test tubes. 4.0 ml of the orcinol reagent was added to it. 
Test tubes were heated on boiling water bath for 15 min, 
cooled and the absorbance was read at 660 nm against a 
reagent blank. 
Calculation: 
Both RNA and DNA were calculated by the following 
formula: C X V 
PNA or DNA (mg/cj fresh tissue wt) = 
Vt X Wt 
where C = Concentration in g in 2.0 ml extract 
Vt = Volume taken for the estimation 
V = Total volume of the extract (4 ml) 
Wt = Fresh weight of tissue in milligram. 
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2.15 Estiiuation of Protein: 
Protein was analysed following the well known method of 
Lowry et al. (1951). Reagents: 
2.15.1 Chemicals and Reagents 
1. Standard solution: A standard solution of 1.0 mg BSA/ml 
was prepared in PBS. 
2. Copper Reagent; 
Reagent A : 4% sodium carbonate in DDW 
Reagent B : 2% copper sulphate in DDW 
Reagent C : 4% sodium-potassium tartarate in DDW 
Copper reagent was prepared by mixing reagents A, B and 
C in a ratio of 100:1:1 respectively at the time of 
use. 
3. Folin-Ciocaltau Reagent: Obtained from Patel Chest 
Institute, New Delhi. 
2.15.2 Procedure: Residue ?.3ft in the test ubes after taking 
the supernatant for nucleic acid estimation, was dissolved in 
5.0 ml DDW. 0.1 ml of the aliquot was taken in the test tubes 
from this solution and the volume was maintained upto 1.0 ml 
with DDW. To this, 5.0 ml of ^opper reagent was added and the 
tubes were shaken thoroughly on a cyclo-mixer. After 10 min, 
1.0 ml of the Follin's reagent (diluted 5 times) was added. 
The intensity of colour was measured at 700 nm after 30 min, 
against a reagent blank. A standard curve of different 
concentrations of BSA (100-600 Mg) was plotted in the same 
way as described above. 
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2.16 MICROANALYSIS OF DIMECRON BY THIN-LAYER CHROMATOGRAPHY: 
The dimecron residue was detected from the central 
nervous system by thin-layer chromatography, and subsequently 
analysed spectrophotometrically using phosphomolybdenum 
method, following the procerdure of Anliker and Menzer 
(1963), modified in this laboratory by Naqvi and Hasan 
(1990) . 
2.16.1 Animals: Twentyfour male albino rats of Charles 
Foster strain, weighing 150 + 20 g were obtained from Central 
Animal House of J.N. Medical College, A.M.U., Aligarh, and 
allowed free access to pellet diet and water. 
2.16.2 Experimental Design: Animals were divided into four 
groups of six each. Freshly prepared doses (1.0, 1.5 and 2.0 
mg/Kg b. wt) of dimecron were administered intraperitoneally 
to the animals of three groups, respectively, for a period of 
seven days. The vehicle used for the dose was physiological 
saline. The fourth group, used as control, received equal 
volume of physiological saline concurrently. 
On the seventh day all the rats were sacrificed by 
cervica] dislocation followed by decapitation. Brains were 
removed and cerebrum, cerebellum, brain stem and spinal cord 
were dissected out rapidly on ice-plate and weighed to the 
nearest milligram. 
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2.16.3 Chemicals and Reagents: 
1. Methylene chloride (A.R.) 
2. Hydrogen peroxide, 30% (A.R.) 
3. Chromatography solvent: 5 parts Petroleum ether (b.p. 
90° - 100°C), 5 parts Toluene, 7 parts Methanol, and 3 
parts DDW were mixed well and the two phases were 
separated. 
4. Blue tetrazolium solution: 3,3-dimethoxy-4, 4-
biphenylene) -bis (2,5-diphenyl-2 H-tetrazolium 
chloride), 0.1% 
5. Potassium permanganate solution, 0.01 N. 
6. Sodium oxalate solution, 0.01 N. 
7. Ammonium molybdate solution, 5% 
8. ANSA solution: 0.2% l-amino-2-naphthol-4-sulfonic acid 
was mixed with 12% sodium metabisulfite and 1.2% 
anhydrous sodium sulfite. 
9. Cone. Sulphuric acid. (A.R.) 
10. Sodium hydroxide, 2 N. (A.R.) 
11. n-Butanol (A.R.) 
2.16.4 Sample preparation: Saline-cleaned and accurately 
weighed CNS parts were homogenized (10% w/v) in methylene 
chloride and centrifuged at 3000 rpm for 20 min. The 
supernatnat was evaporated to dryness and the residue left 
was dissolved in 2.0 ml methylene chloride. 
2.16.5 Tliin-Layer Chromatography: 20 x 20 cm glass plates 
were coated with 0.25 mm silica gel G and dried in over for 2 
hrs. Thereafter, these plates were conditioned by running the 
TIC in ascending order vith the upper phase of the 
chromatography solvent. After drying in air, they are were 
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again subjected to TLC with the lower phase. This 
conditioning of TLC plates was done just prior to use. 
From the sample of each CNS region, 50 Axl aliquot was 
applied one centimeter above the base of pre-conditioned TLC 
plates. The plates were then placed in the chromatography jar 
and thin-layer chromatography was run with upper phase of 
chromatography solvent, and dried in air. The detector (0.1% 
blue tetrazolium solution - 2 NaOH, 1:9 v/v) was then sprayed 
on the plates leading to the appearance of blue spots of 
dimecron (phosphamidon) and its metabolite 
desethylphosphamidon (Fig 3.9). 
Rf values of the spots were measured, and the spots 
scrapped in the test tubes, 2.0 ml of methanol was added to 
it and left for overnight. 
2.16.6 Estimation of 
The tubes were then centrifuged at 5,000 rpm for 10 
min. To the fiDterate, 0.5 ml conc. sulphuric acid and one 
glass beed were added, and the methanol was boiled off on the 
boiling water bath. For Jecolorization, 2-3 drops of H2O2 
were added, and the tubes v;ere again placed on the boiling 
v-ater bath for 5 minutes or until a colourless solution was 
obtained. Tubes were heated for an extra 20 min and then 
cooled in ice. To this, 5.0 ml of DDW as mixed, followed by 
dropwise addition of KMn04 unti] a pink colour persisted. 
One drop of sodium oxalate bulution was added and the pink 
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colour disappeared. Thereafter, the tubes were heated on 
boiling water bath for 20 min. After cooling, 5.0 ml DDW, 0.5 
ml ammonium molybdate solution, and 0.5 ml ANSA solution, 
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were added and again heated on water bath for 20 min, to get 
a blue coloured solution. After cooling in ice, 4.0 ml n-
butanol was mixed while shaking. Two phases were allowed to 
separate. The upper layer was taken in cuvette and the 
optical density was recorded at 790 nm against standard of n-
butanol. 
2.16.7 Preparation of standard curve: The whole process of 
thin-layer chromatography was similarly carried out as 
described earlier, by applying 10, 20, 30, 40, 50, 60 ul of 
dimecron on the TLC plates, instead of brain aliquots, and Rf 
value of the standard dimecron was measured. This was 
followed by preparation of standard curve using 
spectrophotometric estimation of dimecron as described 
earlier in the microanalysis of dimecron in the brain 
samples. 
Calculation: 
C X V 
Concentration of Dimecion (mg/g tissue) = 
Vt X Wt 
where C= Concentration of dimecron in volume taken, (OD x 
factor) 
V= Total volume of homogenate supernatant 
Vt= Volume applied on the TLC plate 
Wt= Fresh weight of the tissue (in g) 
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2.17 Statistical Analysis: 
Results were statistically analysed using 'two-sampled' 
student's 't' test. 'P' values less than 0.05 were considered 
to be significant. 
Moreover, in the Microanalysis of Dimecron, the 
Analysis of Variance (ANOVA) was used for statistical 
analysis of the variations in the accumulation of diwecron 
between various CNS regions and between different doses of 
dimecron. 
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3. RESULTS 
3.1.0 Physical Signs After Dimecron Intoxication 
Dimecron intoxication (2.0 mg/Kg b.wt, ip x 7 days) was 
found to produce physical signs such as muscular 
fasciculations, convulsions and ataxia. After 5-6 days of 
injections, all the treated rats became lethargic. Loss of 
weight of the order of 30-40g, was also noticed on the 
seventh day. 
3.2.0 Open Field Behaviour: 
3.2.1 Effect of Dimecron on Open Field Behaviour (OFB): 
A gradual daily decrease was observed in the open field 
behaviour parameters, i.e. ambulation (Table 3.1), rearing 
(Table 3.2) and rearing (Table 3.3) of the rats treated with 
dimecron (2.0 mg/ kg b.wt. ip) daily for seven days. 
Ambulation and preening scores showed significant 
decrement {P<0.001) from the third day of injections 
onwards. Rearing score, however, was reported to decrease 
significantly (P<0.001) from the fifth day. 
On the seventh and last day, maximum decrease was 
noticed in the rearing score (-95%) as compared to ambulation 
(-89%) and preening (-70%) scores. 
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Fig.3-1 AMBULATION SCORE OF THE RAT TREATED WITH DIMECRON 
PROTECTION BY CITHIOLONE. 
•CONTROL 
DIMECRON ( 2 m g / K g , i p ) 
OIMECRON • CITHIOLONE ( « mg/Kg, ip ) 
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3.2.2 Protective Effect » f Cithiolone Against t h e Dinecron-
induced Perturbation of OFBi 
Interestingly, when the rats were treated with 
cithiolone (8.0 mq/kq b.wt,ip) simultaneously with dimecron, 
no remarkable change was seen in the open field behaviour, 
and ambulation (Table 3.1), rearing (Table 3.2) and preening 
(Table 3.3) scores werf observed to be near the normal 
(control) values throughout the seven days of experiment. 
Figures 3.1, 3.2 and 3. c3early depict the protection by 
cithiolone against the effeccs of dimecron on the ambulation, 
rearing and preening, respectively. 
3.3.0 Acetylcholinesterase 
3.3.1 Effect of Dinecron on Acetylcholinesterase: 
Dimecron toxicosic (2.0 mg/kg b. wt. ip x 7 days) was 
found to induce significant inhibition of 
acetylcholinesterase (AChE) activity (Table 3.4). Inhibition 
of AChE was reported in cerebrum, brain stem, spinal cord 
(P<0.001) and cerebellum (ir<(i.01). Spinal cord showed maximum 
AChE depletion .(-27%). 
3.3.2 Protective Effect or Cithiolone Against Di»ecron-
induced AChE inhib: .. 
Simultaneous treatment of cithiolone (8.0 mg/kg wt, ip) 
alongwith dimecron was reported to protect remarkably against 
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F)G.3 : DIMECRON INDUCED ALTERATION OF AChE A C T I V I T Y ! 
PROTECTION BY CiTHlOLONE. 
1 2 3 4 5 
p. MOLES OF ACETYLCHOLINE IODIDE H Y D R O L Y Z E D / g T I S S U E / MIN . ) 
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diitiecron induced depletion of AChE activity in all the CNS 
regions (Table 3.5). 
Notably, when rats were exposed to cithiolone alone 
(Table 3.6), significant elevation of AChE activity (P<0.001) 
was seen in the cerebrun, cerebellum, brain stem and spinal 
cord, with the maxinium elevation being noted in the spinal 
cord. 
Figure 3.4 clearly depicts effect of dimecron on the 
AchE; Correlated with protection by cithiolone. 
3.4.0. Effect of Dinecron on Brain Honoanines 
Level of monoamines was reported to deplete 
significantly in all the CNS regions of the rats intoxicated 
with dimecron (2.0 mg / Kg b.wt. ip) daily for seven days. 
Dopamine (DA) was found to decrease (Table 3.7) in 
cerebrum, cerebellum, brain stem (P<0.010) and spinal cord 
(P<0.001). Cerebellum and brain stem showed the maximum (-
24%) and minimum (-14%) decrement, respectively. Table 3.8 
portrays the diminished contents of norepinephrine (NE) in 
cerebrum (P<0.01), cerebellum (P<0.05), brain stem (P<0.001) 
and spinal cord (P<0.02), with the greatest depletion found 
in the brain stem (-21%). Serotonin (5-HT) also showed 
depletion (Table 3.9) in cerebrum, spinal cord (P<0.01), 
cerebellum (P<0.02) and brain stem (P<0.001). Maximum 
decrease was found in cerebrum (-22%) . 
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3.5.0 Monoamine Oxidase (MAO) in Brain 
3.5.1 Effect of Diinecron on MAO Activity 
Following diinecron administration (2.0 mg/kg b.wt. ip x 
7 days), the activity of monoamine oxidase vas significantly 
(P<0.001) enhanced in all the regions of the CNS. 
Elevation of the MAO activity was found of the order of 
21% in cerebrum, 24% in cerebellum, 19% in brain stem and 23% 
in spinal cord (Table 3.10). Notably, cerebellum and brain 
stepi showed maximum and minimum increment, respectively. 
3.5.2. Protective Effect of Cithiolone on the Dimecron-
induced MAO Elevation 
Interestingly, a remarkable protection against the 
effect of dimecron was observed on the MAO activity, when the 
rats were treated with cithiolone (8.0 mg / kg b.wt,ip) 
simultaneously with dimecron (Table 3.11). No significant 
change as compared to the control values, was observed in the 
MAO activity of all the CNS regions. 
When cithiolone was administered alone, however, 
significant inhibition (P<0.001) was noted in the activity 
of MAO in all the regions, with the maximum and minimum 
depletion, being observed in cerebellum (-28%) and brain stem 
(-21%), respectively (Table 3.12). Protective effect of 
cithilone on the MAO activity is shown in Fig. 3.5 
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3.6.0. Effect of Dimecron on Brain Lipids 
Effects of dimecron (2.0 mg/kg b. wt. ip x 7 days) were 
studied on the concentration of total lipids, phospholipids, 
cholesterol and gangliosides in various regions of the CNS. 
3.6.1. Total Lipids 
Table 3.13 describes the alterations in the 
concentration of total lipids in various CNS regions 
following dimecron toxicity. 
Total lipids were found to decrease considerably in 
cerebrum (P<0.001), cerebellum, brain stem (P<0.01) and 
spinal cord (P<0.05), with the most significant change 
(-21%) , observed in cerebrum. 
3.6.2. Phospholipids 
Phospholipid contents diminished significantly 
(P<0.001) in all the CNS regions after dimecron toxicosis 
(Table 3.14). Cerebrum showed maximum (-57%) depletion, while 
the minimum depletion was found in brain stem (-29%). 
Cerebellum and spinal cord revealed decrement of 
phospholipids of the order of -46% and -36%, respectively. 
3.6.3. Cholesterol 
Dimecron intoxication led to remarkable decrement in 
the 3evel of cholesterol (Table 3.15) in the cerebrum, 
cerebellum (P<0.001) and spinal cord (P<0.01). Maximum 
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decrease was reported in the cerebrum (-35%) while a non-
significant change was seen in the brain stem (-5%). 
3.6.4. Gangliosides: 
The concentration of total gangliosides was found to 
diminish significantly (P<0.001) in cerebrum, cerebellum and 
brain stem (Table 3.16) following dimecron toxicosis. In the 
spinal cord, however, the change was not significant (-13%). 
3.7.0. Lipid Peroxidation in Brain 
3.7.1. Effect of Dimecron on Lipid Peroxidations 
The rate of lipid peroxidation was reported to enhance 
significantly in various regions Of the CNS following 
intoxication with dimecron (2.0 mg / kg b. wt, ip) daily for 
seven days (Table 3.17), 
Significant increment was observed in cerebellum 
(P<0.02), brain stem and spinal cord {P<0.001). 
3.7.2. Protective Effect of Cithiolone Against Dinecron-
induced Elevation of Lipid Peroxidation: 
Interestingly, when cithiolone (8.0 mg/kg b.wt, ip) was 
administered simultaneously with dimecron, a remarkable 
protection against elevation of the rate of lipid 
peroxidation was obsei.» - (Fig. 3.6). The rate of lipid 
peroxidation was reported to be near the control values in 
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FiQ.3-6.DIMECR0N INDUCED ALTERATION IN RATE OF 
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cerebrum, cerebellum, brain stem and spinal cord (Table 
3.18). 
Significant depletion in the rate of lipid 
peroxidation, however, was observed in cerebellum (P<0.01), 
brain stem and spinal cord (P<0.001), when the rats were 
exposed to cithiolone alone (Table 3.19). 
3.8.0 Effect of Diwecron on Sulfhydryl Groups in Brain 
Alterations in the content of total, non-protein bound 
(NPB) and protein-bound sulfhydryl (-SH) groups in various 
CNS regions of the dimecron (2.0 mg / kg b. wt. ip x 7 days) 
treated rats are depicted in Tables 3.20, 3.21 and 3.22, 
respectively. 
3.8.1. Total -SB Groupst 
The content of total -SH groups were reported to 
decrease significantly (i?<.0.001) in all the CNS regions 
following dimecron toxicosis (Table 3.20). 
Spina] cord showed indAimum decrement, of the order of -
45%, as compared to cerebrum (-41%), cerebellum (-22%) and 
brain stem (-40%). 
3.8.2. Non-protein Bound -SH Groups 
Significant depletion (P<0.001) was observed in the 
concentration of NBP-SH groups in all the regions of the CNS, 
after exposure to dimecron, as shown in Table 3.21. A greater 
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depletion was noticed in brain stem (-45%) and spinal cord 
(-46%), as compared to cerebrum (-27%) and cerebellum (-35%) . 
3.8.3. Protein Bound -SH Groups: 
Following dimecron intoxication, the content of 
protein-bound -SH groups were found to diminish significantly 
(P<0.001) in cerebrum, brain stem and spinal cord, cerebrum 
showing the maximum depletion (-49%). Cerebellum, however, 
showed a non-significant depletion (-8%). 
3.9.0. Glutathione-S-transferase (GST) in Brain 
3.9.1 Effect of Di»ecron on Glutathione-S-transferase 
Activity: 
Dimecron intoxication (2.0 mg / kg b. wt. ip x 7 days) 
led to a significant inhibition in the activity of GST 
(P<0.001) in all the CNS regions (Table 3.23). 
Brain stem (-32%) and spinal cord (-42%) were reported 
to deplete more significa.uly, as compared to cerebrum (-19%) 
and cerebellum (-26%). 
3.9.2. Protective Effect of Cithiolone Against GST 
Inhibition: 
Fig. 3.7 shows the protective effect of cithiolone 
against the dimecron-induced inhibition of GST. When rats 
were treated with cithiolone (8.0 mg / kg b.w.t, ip) 
simultaneously with dimecron, no significant change was noted 
in the activity of GST in all the CNS regions and the 
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Fig.3-7. CITIOLONE INDUCED PROTECTION OF GST ACTIVITY AGAINST 
INHIBITION BY PHOSPHAMIDON INTOXICATION. 
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activity of the enzyme was seen to be near the control values 
(Table 3.24) . 
V7hen treated with cithiolone alone (Table 3.25) 
however, the activity of GST was reported to enhance 
significant]y (F<0.001) in cerebrum (14%), cerebellum (16%), 
brain stem (16%) and spinal cord (19%). 
3.10.0 Superoxide Dismutase (SOD) in Brain 
3.10.1 Effect of Dimecron on Superoxide Dismutase activity: 
The activity of superoxide dismutase was found to 
decrease in all the CNS regions of dimecron-treated (2.0 
nio/kg b. wt. ip x 7 days) rats (Table 3.26). 
SOD activity was inhibited in cerebrum (P<0.02), 
cerebeJJuiri, brain stem and spinal cord (P<0.001), Inhibition 
was noticed to be more prominent in brain stem (-35%) and 
spinal cord (-48%), compared to cerebrum (-16%) and 
cerebellum (-22%). 
3.10.2 Protective Effect of Cithiolone Against SOD Inhibition: 
Protective effect of cithiolone against dimecron-
induced inhibition of SOD is described in Fig. 3.8. Following 
the simultaneous treatment of cithiolone (8.0 mg / kg b.wt, 
ip) and dimecron, no significant change in the SOD activity 
vvs& obE^erved in any of the investigated CNS regions (Table 
3.27) . 
However, cithiolone intoxication alone, was reported to 
induce significant increment of the SOD activity in cerebrum 
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(P<0.01), cerebellum, brain stem and spinal cord (P<0.001), 
with maximum elevation found in the spinal cord (+23%) , as 
shown in Table 3.28. 
3.11.0. Nucleic Acids in Brain 
3.11.1 Effect of Dimecron on DNA 
The concentration of deoxyribonucleic acid (DNA) was 
found depleted significantly (P<0.001) in cerebrum, 
cerebellum, brain stem and spinal cord of dimecron-treated 
(2.0 mg/kg b. wt. ip x 7 days) rats (Table 3.29). Cerebrum 
showed the greatest decrement in the DNA content (-45%). 
3.11.2 Effect of Dimecron on RNA: 
Table 3.30 reveals neurochemical alteration in the 
levels of ribonucleic acid (RNA) following dimecron toxicosis 
(2.0 mg / kg b. wt. ip x 7 days). RNA content was reported to 
increase in cerebrum (P<0.01), cerebellum, brain stem and 
spinal cord (P<0.001). Maximum increment (33%) was seen in 
the spinal cord. 
3.12.0. Effect of Dimecron on Brain Protein Level 
Dimecron intoxication (2.0 mg/kg b. wt.ip x 7 days) led 
to significant decrease {P<0.001) in the total protein 
contents of cerebrum, cerebcllum, brain stem and spinal cord, 
as depicted in Table 3.31. Protein depleted most prominently 
in the cerebrum (-22%). 
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3.13.0 Accumulation of Dimecron in t h e CNS: 
Diinecron was recovered, using thin layer chromatography 
(TLC), from various CNS regions of the rats intoxicated with 
three graded doses of dimecron (1.0, 1.5 and 2.0 mg / kg b. 
wt, ip X 7 days). The Rf value of dimecron, as evaluated from 
the spots of dimecron which appeared on the TLC plates (Pig. 
3.9), was found to be equal to 0.36. 
A remarkable dose-related elevation was observed in the 
concentration of dimecron accumulated in all the CNS regions, 
i.e., cerebrum, cerebellum, brain stem and spinal cord (Table 
3.32). 
Cerebrum showed maximum percent recovery compared to 
concentration of dose injected, in all the three dose groups 
(22.2, 22.3 and 24.2%, respectively). 
Trends of ANOVA revealed that all the variations, 
between various regions as well as between different doses, 
were highly significant (P<0.001). 
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Fig 3.9a Photograph of thin-layer chromatogram showing 
separated spots of dimecron (phosphamldon) and its 
metabolite desethylphosphamidon, detected by TLC 
from discrete CNS regions. 
P: Phosphamidon spot, D: Desethylphosphamidon spot 
CB,CL, BS and SC: Origin points of samples from 
cerebrum, cerebellum, brain stem and spinal cord, 
respectively. 
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Fig.3-9. DOSE-RELATED ACCUMULATION OF DIMECRON IN THE 
CNS.AS DETECTED BY T.L.C. . 
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4- DISCUSSION 
Organophosphate pesticides have been extensively 
studied regarding their neurochemical and neurobehavioral 
effects on the non-target organisms. To date, very little 
literature is available, however, on the neurotoxicity of 
dimecron (phosphamidon), a widely used, potent but relatively 
less studied organophosphate pesticide. 
The present study demonstrates regional heterogeneity 
not only related to the effects of dimecron on various 
neurochemical and neurobehavioral parameters, but also in the 
extent of these adverse effects on the different regions of 
the CNS. These regional variations might be explained keeping 
in view the fact that the brain is a very complex organ 
composed of many structural and functional components with 
markedly different and independently regulated levels of 
functional and metabolic activities. It is difficult to 
assess the levels of functional and metabolic activities at 
the same time (Sokoloff .15*79). This heterogeneity of the 
brain is of great importance in the evaluation and 
interpretation of the biocii.. ical findings (Hertz 1969) . 
4.1.0 Acetylcholinesterase: 
Acetylcholinesterase (AChE) is regarded as a tool for 
quantification of organophotjphate induced effects (Voss 
1968). Although, quite a large number of previous studies 
have reported inhibition of AChE by OP poisoning, very little 
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information is available regarding neurotoxic effect of 
dimecron on the AChE activity. 
The present study discloses a remarkable depletion of 
AChE activity in various CNS regions following dimecron 
toxicosis (Table 3.4). 
Most of the organophosphorus compounds act by 
disrupting the nerve impulse due to the accumulation of 
acetylcholine (ACh) at the synapses following AChE inhibition 
(Paul et al 1979). This supports the inhibition of AChE 
reported in this study. Our results are also supported by a 
number of previous reports (DuBois et al 1979; Emsley et al 
1976; Paul et al 1979; Hall and Kolbe 1980) revealing AChE 
depletion after organophosphate poisoning. From this 
Laboratory, Ali et al (1977) have also reported inhibitory 
effect of dichlorvos on the AChE activity. Emsley et al 
(1976) suggested that the CP pesticides inhibit the activity 
of AChE through crossing-over the blood-brain barrier (BBB), 
which is also supported by a recent finding of Naqvi and 
Hasan (1990), who showea dose-dependent accumulation of 
dimecron in the central nervous system, obviously by crossing 
the BBB. 
Accumulation of ACh at the synapses, resulting from 
AChE inhibition, has been suggested to induce cholinergic 
excitation which causes reduction of the monoaminergic 
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neurotransmitters (Tracy et al 1960). Dimecron has been found 
to deplete the levels of brain monoamines (Naqvi and Hasan 
1991b)f which also endorses the AchE reduction (Naqvi and 
Hasan 1991c) . Brezezinski (1978) and Brezezinski and 
Paruszewska (1980) have also reported decrease in the brain 
neurotransmitter levels in the organophosphate-treated rats. 
Moreover OP-induced increase in the content of acetylcholine 
was reported by Hall and Kolbe (1980) , which is also 
consistent with the depletion of acetylcholinesterase. 
Previously, it was assumed that the AChE inhibition is 
an irreversible process (Weiss 1959; Murphy et al 1968; 
O'Brien 1976). Subsequent studies, however pointed out the 
inhibition of AChE following organophosphate toxicity, may be 
reversed also (Muthazhagu 1985; Khan 1989). 
Interestingly, the present study reveals a remarkable 
protection against dimecroK-induced depletion of AChE in all 
the CNS regions when the rats were treated with cithiolone 
simultaneously with dimecron (Table 3.5). This can be 
explained by the fact that cithiolone (acetyl homocysteine 
thiolactone) , an antioxidant, probably dissociates the AChE-
anti AChE complex, leading to reactivation or detoxification 
of acetylcholinesterase. Dissociation of ChE-anti ChE complex 
has been found to play a very vital role in the 
detoxification process (Lauwerys and Buchet 1971). The 
stability of the phosphorylated enzyme depends upon the 
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nature of the pesticide fReiner 1971). Moreover, cithiolone 
(acetylhomocysteine thiolactone) has been reported to protect 
against dimecron neurotoxicity (Naqvi and Hasan 1991a). 
Elevation in the activity of AChE in the CNS regions of the 
cithiolone-intoxicated rats (Table 3.6) also supports the 
suggestion that cithiolone reactivates the enzyme activity. 
4.2.0 Monoamine Metabolism and Neurobehavlour: 
4.2.1 Monoamines and Monoamine Oxidase: 
Monoamines, consisting of dopamine (DA), norepinephrine 
(NE) and serotonin (5-HT) act as important neurotransmitters 
in the neuronal transmission system. 
Dimecron intcxicauion has been found to significantly 
diminish the levels of DA, NE and 5-HT in the cerebrum, 
cerebellum, brain stem and spinal cord, as reported in this 
study (Tables 3.7, 3.8 and 3.9). 
It has been universally accepted that the 
organophosphate-induced inhibition of AChE results in 
accumulation of acetylcholine (ACh) at the synapses (Paul et 
al 1979), leading to disruption of nerve impulses. This 
accumulation of ACh has been reported to stimulate 
cholinergic excitation, which in turn, may deplete the 
monoamine levels (Tracy et. al 1960; Burn and Rand 1965; 
Brezezinski 1972). This is ..^ 11 in agreement with our results 
(Tables 3.7, 3.8, 3.9) revealing significant decrement in the 
concentration of DA, NE and 5-HT in cerebrum, cerebellum. 
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brain stem and spinal cord following dimecron intoxication 
(Naqvi and Hasan 1991b). Decreased monoamine levels in the 
CNS, following toxicosis with organophosphate dichlorvos, has 
also been reported by Ali et al (1980). They have, 
additionally, correlated depletion of 5-HT with increased 
motor activity, as 5-HT is said to account for enhanced motor 
activity (Scheckel et al 1969). 
Monoamine oxidase (MAO) plays an important role in the 
metabolism of biogenic amines and in the behaviour (Shellen-
berger and Walaszec 1972; Chase and Murphy 1973). It is 
involved in the enzymatic deamination and subsequent 
degradation of biogenic amines (Cooper et al 1978). Elevation 
of MAO activity in various regions of dimecron-poisoned rats 
(Table 3.10) can, therefore, be correlated with the 
diminution of brain monoamine levels reported in this study 
(Naqvi and Hasan 1991 b). Alteration of MAO activity has been 
associated with convulsive seizures (Kilien and Frey 1973), 
which is supported by severe convulsions following dimecron 
poisoning, reported in this study. Moreover, Beeman and 
Matsumura (1973) have also shown that MAO activity is 
inversely proportional to the monoamine levels. 
Interestingly, maximum inc^rement of MAO activity was observed 
in cerebellum which is in concordance with maximum depletion 
of DA content in that region. Concomitantly, the brain-stem 
showed minimum MAO enhancement and DA decrement. This can be 
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explained on the basis of the suggestion that the gray 
matter-rich cerebellum is likely to be affected by a toxicant 
more severely compared to white matter-rich brain stem (Naqvi 
and Hasan 1990), because the blood flow in the gray matter is 
reported to be many times higher than in the white matter 
(Landau et al 1955). However, in the cerebrum, which is also 
a gray matter-rich region, comparatively lower diminution of 
monoamines was observed. This contradiction may be explained 
by the higher lipid content of cerebrum as compared to 
cerebellum (Naqvi et al 1988; Gupta and Hasan 1988). This 
suggests a greater white matter fraction in the cerebrum, and 
hence the lesser diminution of monoamines in that region is 
not surprising, owing to known differences in the blood 
perfusion rates of cerebellum and cerebrum. 
Interestingly, a remarkable cithiolone-induced 
protection against the MAO elevation was noticed in all the 
CNS regions (Fig. 3.5). The activity of MAO was reported to 
be near the control values in the CNS regions of rats 
subjected to simultaneous treatment of cithiolone and 
dimecron (Table 3.11). This protection may be the result of 
detoxication against dimecron neurotoxicity by cithiolone, a 
potent antioxidant which has been reported to protect against 
adverse effects of dimecron on the CNS (Hasan et al 1987; 
Naqvi and Hasan 1991a). Moreover when the rats were exposed 
to cithiolone only, MAO activity inhibited in all the regions 
(Table 3.12). It is, therefore, also possible that the 
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reported protection might be due to ability of cithilone to 
deplete the MAO activity and thus neutralizing the dimecron-
induced elevation of the enzyme. 
4.2.2. Open Field Behaviour: 
According to Parale and Kulkarni (1986), the 
organophosphate-induced cholinergic stimulation in the brain 
leads to reduction of the central adrenergic activity, which 
is very important in the pathogenesis of behaviour. 
Furthermore, it has been suggested that alterations in the 
biochemical mechanisms and biogenic amine concentrations 
manifest varying disorders in the behaviour (Taylor and 
Snyder 1971; Kaloyanova et al 1979). 
Accordingly, the present study reports a remarkable 
change in the open field behaviour (OFB) of the dimecron-
treated rats. Significant day-to-day decrement was observed 
in the scores of OFB parameters, i.e. ambulation, rearing and 
preening (Naqvi & Hasan 1991b). 
Ambulation and rearing are known to be horizontal 
(simple) and vertical (complex) stereotypy, respectively 
(Dandiya et al 1969; Gupta and Holland 1972). Decrement of 
ambulation (Table 3.1) and rearing (Table 3.2) scores can 
therefore be correlated with the depleted DA content (Table 
3.7), as DA in the main modulator of stereotype behaviour 
(Kulkarni and Dandiya 197-^; . Rearing is also indicative of 
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cortical stimulation (Lat 1965), while preening response has 
been described as a behavioural correlate of cortical 
stimulation (Gupta et al 1971). Depression of preening score 
(Table 3.3) can therefore be related to the diminution of 
cortical stimulation, i.e. rearing. Our results (Naqvi & 
Hasan 1991b) are further supported by the findings of Ali et 
al (1980), showing decrease in the OFB parameters alongwith 
depletion of brain monoamines following intoxication with 
organophosphate, dichlorvos. The dose-response signs of 
dimecron toxicity, viz. fasciculations, convulsions, ataxia 
and lethargy, are also in agreement with decrease in the 
ambulation, rearing and preening scores. 
Remarkable protection against the behavioral changes 
was observed following simultaneous treatment with cithiolone 
alongwith dimecron. Scores of ambulation (Fig. 3.1), rearing 
(Fig. 3.2) and preening (Fig. 3.3) showed no significant 
alteration throughout the seven days of exposure. This 
protection is well supported by the detoxifying ability of 
antioxidant cithiolone against dimecron neurotoxicity (Hasan 
et al 1987; Naqvi and Hasan 1991a). Moreover, protection 
against dimecron-induced elevation of MAO (Fig. 3.5) are also 
in concordance with the protection against behavioral 
changes. 
4.3.0 Brain Lipids: 
Findings of the present investigation reveal decrement 
in the levels of total lipids, phospholipids, cholesterol and 
167 
gangliosides following the dimecron toxicosis (Naqvi et al 
1988) . 
4.3.1. Total Lipids: 
Brain is one of the richest in lipids among the various 
body organs. Lipids account for about half the dry weight of 
most of the structural architecture of membranes in the brain 
(Ordy and Kaack 1975) . They also constitute components of the 
ion channels, portions of the neurotransmitter receptors, and 
are major constituents of myelin. Myelin sheath and neuropil 
of gray matter account for much of the total lipid contents 
of the brain tissue (Scharf 1953; Schimizu 1965), making upto 
65% of the weight of white matter and 35-40% of gray matter 
(Brante 1949) . Lipids of various tissues are known to be in a 
dynamic steady state and there is continuous replacement of 
existing molecules by new ones (White et al 1959). It is 
noteworthy that distinct regional differences occur in lipid 
contents and its turn-over in various pathways and centres of 
the mammalian brain. Alterations in the lipid metabolism may 
be due to changes in the rate of anabolism, catabolism, or 
both. These processes are regulated by the activities of 
appropriate enzymes. 
The dimecron-induced depletion of total lipid content 
(Table 3.13) are supported by the findings of Majno and 
Karnovsky (1955) who reported perturbed lipid synthesis in 
the brain after organophosphate poisoning. Diminution of 
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total lipids suggests a possible increase in the degradation 
of lipids, as evident by the increased rate of lipid 
peroxidation and lipase activity following organophosphate 
toxicity (Islam et al 1983; Tayyaba and Hasan 1985; Hasan and 
Khan 1985; Vadhwa and Hasan 1986; Naqvi et al 1988). Ham and 
Rose (1969) and Hazzard et al (1969) have suggested that 
changes in the lipase activity may be an important factor 
contributing to perturbed plasma lipid levels. Moreover, 
Haider et al (1981) have also correlated decreased lipid 
contents in various regions of the brain with enhanced lipase 
activity in those regions. 
4.3.2. Phospholipids: 
Phospholipids play an important role in the CNS as 
essential membrane constituents. The properties of a 
membrane, therefore depend, to some extent, on the 
phospholipid composition. The myelin of phospholipids remain 
almost stable throughout the life span of the animal (Davison 
and Dobbing 1960). Individual lipid classes, specially 
membrane phospholipids are undergoing constant turnover at 
different rates with respect to the structure of the lipid 
and localization in various; cells and membranes (Porcellati 
1983) . The depletion of phospholipid levels in different CNS 
regions of dimecron-treated rats (Table 3.14), can be 
supported by the findings of Nelson and Barnum (1960) who 
observed inhibition of phospholipid biosynthesis by the 
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administration of diisopropylfluorophosphate (DFP). Moreover, 
Tayyaba and Hasan (1980) have also reported decrement of 
phospholipid contents in the CNS regions following metasystox 
intoxication, which also endores present findings. 
4.3.3. Cholesterol: 
Cholesterol is present in large amounts in the CNS. It 
occurs in white matter in amounts exceeding those in gray 
matter (Brante 1949). It is the characteristic lipid of 
myelin sheath. The constant amount of cholesterol in the 
brain suggests that the sterol is metabolically stable and is 
thus excluded from the normal dynamic exchange process conimon 
to almost all other body constituents (Waelsch et al 1940). 
About 70% of the total brain cholesterol is present in the 
myelin (Dobbing 1964). Demyelination caused by 
organophosphate toxicity or multiple sclerosis leads to loss 
of cholesterol esters (Davison and Wajda 1962). Moreover, 
Majno and Karnovsky (1961) observed that mipafox, an OP 
pesticide, inhibited the incorporation of acetate, choline 
and phosphate into the lipids of CNS. This is well in 
agreement with the dimecron-induced decrease in the content 
of cholesterol in various regions of the CNS (Table 3.15). 
4.3.4 Gangliosides: 
Gangliosides are known to be involved in the synaptic 
transmission, since they act as receptor sites for various 
neurotoxins (North et al 1961) . Gangliosides are generally 
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synthesised in neuronal perikarya and are transported to the 
nerve endings along with macromolecules (Rahman and Rosner 
1973; Ledeen et al 1976; Landa et al 1979), but local 
synthesis within the axons and nerve endings (Ledeen et al 
1976) or even at the plasma membrane level (Preti et al 1980) 
can not be excluded. Gangliosides are essential membrane 
constituents and are more concentrated and complex in the CNS 
than in any other organ (Rahman 1983) . Gangliosides may bind 
biologically active compounds as well as various neurotoxins, 
through their terminal N-acetylneuraminic acid moiety (Avrova 
1971). 
To our knowledge, no previous report is available on 
the neurochemical effect of dimecron on brain gangliosides. 
However, the degradation of gangliosides in various CNS 
regions following dimecron intoxication (Table 3.16) can be 
explained by the suggestion of Ledeen and Mellanby (1977), 
that the reduction of gangliosides occurs through sequential 
removal of neuraminic acid by neuraminidases. Findings of 
Islam et al (1983), revealing metasystox-induced decrement of 
brain ganglioside contents, also support the results of this 
study (Table 3.16). Depletion of gangliosides has also been 
reported by methyl parathion toxicosis (Khan and Hasan 1988). 
Degradation of brain gangliosides (Naqvi et al 1988) 
can also be correlated with the dimecron-induced 
perturbations in the open filed behaviour (Naqvi and Hasan 
1991b), as Irwin and Samson (1971) have suggested that 
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certain types of behavioral stimulations seem to be 
accompanied by alterations in the ganglioside metabolism. 
4.4.0. Lipid Peroxidation; 
Investigation of lipid peroxidation is a recently 
applied approach to the study of neurotoxicity (WHO 1986). 
Lipid peroxidation is the basic mechanism of oxidative 
destruction of polyunsaturated fatty acid chains in 
biological membranes. It involves direct reaction of oxygen 
and lipid molecule which leads to the formation of free 
radical intermediates, and subsequently semi-stable 
peroxides. 
Biomembranes and subcellular organelles are the major 
sites of lipid peroxidation damage (Tappel 1970). Among the 
different tissues, brain has been reported to show 
considerably high degree of peroxidation, probably due to the 
fact that brain has the highest content of lipids compared to 
other organs (Kartha and Krishnamurthy 1978) . Lipid 
peroxidation appears to be a phenomenon that reflects free-
radical events associated with biological membranes which 
contain most of the polyunsaturated fatty acid-containing 
lipids. The brain homogenate has apparently the necessary 
unsaturated fatty acids and the catalysts for peroxidation in 
the architecture of the cell itself, which are readily 
available for reaction with molecular oxygen to undergo lipid 
peroxidation. 
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Free radical mechanism leading to lipid peroxidation 
and degradation of brain lipids with the loss of membrane 
integrity is considered to be important factor in the 
development of irreversible damage of brain cells during 
ischaemic and other adverse conditions (Demopoulos et al 
1979) . 
Following intoxication with dimecron, lipid 
peroxidation was found enhanced in all the regions of the CNS 
(Table 3.17). This enhancement (Naqvi et al 1982) can be 
supported by the findings of Hasan and Ali (1981) disclosing 
increment of the rate of lipid peroxidation following 
administration of organophosphate dichlorvos. Similar results 
have been observed by intoxication with metasystox (Islam et 
al 1983; Tayyaba and Hasan 1985) and methyl parathion (Hasan 
and Khan 1985). Furthermore, Haider et al (1982) have 
suggested that increment of lipid peroxidation might 
contribute to the decrement of lipid levels in various brain 
areas. Elevation of lipid peroxidation can also be correlated 
with depletion of the sulfhydryl group contents in the CNS 
regions following dimecron toxicity (Naqvi and Hasan 1991a) , 
because it has been suggested that decrement of sulfhydryl 
groups may lead to deficient degradation of lipid peroxides 
to hydroxyacids, causing increment of lipid peroxides in the 
tissue (Tappel 1970). 
Interestingly, an antioxidant agent, cithiolone, has 
been found to protect against dimecron-induced elevation of 
173 
lipid peroxidation (Fig. 3.6). When the rats were 
simultaneously treated with cithiolone and dimecron, no 
significant change was observed in the rate of lipid 
peroxidation in any of the CNS regions (Table 3.18). Lipid 
peroxidation was decreased, however, following the 
administration of cithiolone, alone (Table 3.19). Since lipid 
peroxidation is an oxidative process, its decrement by the 
antioxidant cithiolone can well be understood. It can be 
assumed that cithiolone may probably act as 'in vivo' lipid 
antioxidant, protecting unsaturated fatty acids in the tissue 
lipids against peroxidation. Bieri and Anderson (1960) 
suggested that each tissue has an "antioxigenic" potential 
which is determined by a balance between factors promoting 
peroxidation and by those exerting an antioxidant action. 
Protective effect of cithiolone against the OP induced 
increment of lipid peroxidation have also been reported by 
Hasan et al (1987) which support the present findings (Table 
3.18). Moreover, Tayyaba and Hasan (1985) have observed 
protection against metasystox-induced elevation of lipid 
peroxidation by the simultaneous treatment of another 
antioxidant. Vitamin E. 
It can, therefore, be concluded that the peroxidation 
of endogenous lipids was enhanced by dimecron intoxication, 
resulting in the fragmentation of lipids, thereby leading to 
disintegration of membrane structure and finally to cell 
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damage. This can however be protected by antioxidant, 
cithiolone, owing to its free-radical scavenging and 
antioxidative effects. 
4.5.0. Sulfhydryl Groups: 
Sulfhydryl (-SH) groups act as important enzymatic 
sites (Hoch and Vallee 1959). According to Chio and Tappel 
(1969), sulfhydryl enzymes are most susceptible to lipid 
peroxide-induced inactivation. Glutathione (GSH) has been 
reported to play a protective role against free radical-
mediated or peroxidative damage (Stokinger and Coffin 1968; 
Little and O'Brien 1968; DeLucia et al 1972; Chow and Tappel 
1972). GSH, which is a potent nucleophile, is involved in 
conjugation reactions which are important for detoxication 
against electrophilic toxicants (Chasseaud 1980). This 
conjugation reaction between -SH group of glutathione and the 
toxic compound, has been reported to be catalyzed by an 
enzyme glutathione-S-transferase (GST) (Grover and Sims 1964; 
Boyland and Chasseaud 1969; Habig et al 1974; Al-Turk et al 
1987) . 
The present study reveals significant depletion in the 
concentration of total (Table 3.20), non-protein bound (Table 
3.21) and protein bound (Table (3.22) sulfhydryl groups in 
all the CNS regions following dimecron intoxication. This 
depletion may be supported by our findings indicating 
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dimecron-induced decrement in the activity of GST in the CNS 
regions (Naqvi and Hasan 1991a) . 
Moreover, since sulfhydryl groups are involved in the 
cellular detoxication against peroxidative damage (Chow and 
Tappel 1972), the diminution of sulfhydryl group contents can 
also be correlated with dimecron-induced enhancement of lipid 
peroxidation in the CNS (Naqvi et al 1988). This can be 
explained by the suggestion of Tappel (1970) that depletion 
of sulfhydryl groups may lead to deficient degradation of 
lipid peroxides to hydroxy acids, resulting in the increment 
of lipid peroxide contents. 
4.6.0 Glutathione-S-transferase: 
Glutathione-S-transferase (GST) represents an important 
class of xenobiotic metabolising enzymes (Mukhtar et al 
1981) . GST has been shown to be present in the mammalian and 
avian brain, besides its wide distribution in the body (Dixit 
et al 1981). Brain GST has been reported to play an important 
role in the detoxication of potential toxicants through their 
conjugation and biotransformation (Booth et al 1961; Boyland 
and Chasseaud 1969; Wood 1970; Dixit et al 1980). Jakoby and 
Keen (1977) have proposed that GST provides a "sacrificial" 
covalent linkage for eJectrophilic neurotoxic compounds. 
Our findings indicating dimecron-induced inhibition of 
GST in all the CNS regions (Table 3.23), can, therefore, be 
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the result of cumulative effect of dimecron, inhibiting its 
GST-mediated biotransformation pathway. This may be a 
critical factor for the neurotoxic effect of any toxicant, 
which requires disposal through GST conjugation. Moreover, 
Boyland and Chasseaud (1969) and Das et al (1982) have 
suggested that greater accumulation of the toxic compound may 
inhibit the GST. Dimecron readily crosses the blood-brain 
barrier and we have already reported its accumulation in the 
CNS following graded dosing (Naqvi and Hasan 1990), which 
clearly supports GST inhibition following dimecron toxicosis. 
GST has been reported to initiate detoxication process 
by catalyzing the conjugation reaction between the 
electrophilic toxicant and sulfhydryl group of glutathione 
(GSH), a nucleophile (Grover and Sims 1964; Boyland and 
Chasseaud 1969; Habig et al 1974). The dimecron-induced 
depletion of the GST activity may also be correlated with 
diminution of the level of sulfhydryl groups in the CNS 
regions following administration of dimecron (Naqvi and Hasan 
1991a). 
Cithiolone, an antioxidant compound, however was 
reported to protect against the dimecron-induced inhibition 
of GST (Fig. 3.7). The activity of GST was observed to be 
near the control values in all the CNS regions of the rats 
subjected to simultaneous treatment of cithiolone and 
dimecron (Table 3.24). Notably, the GST activity was enhanced 
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when cithiolone was administered alone (Table 3.25). This 
suggests that the protection of GST may probably be due to 
reactivation of the enzyme by cithiolone, thereby enhancing 
its capability to initiate detoxication against dimecron 
toxicity (Naqvi and Hasan 1991a). 
It can be concluded that the inhibition of brain GST, 
resulting from binding of the enzyme by dimecron, may lead to 
an overall suppression of the biotransformation and 
detoxication reaction, resulting in an increased 
vulnerability of the brain regions to the exposure of 
dimecron toxicosis. Antioxidant, cithiolone interestingly 
protects against dimecron neurotoxicity by reactivating and 
hence increasing the detoxication potential of GST. 
4.7.0. Superoxide Dismutasej 
The activity of superoxide dismutase (SOD) was found to 
diminish in cerebrum, cerebellum, brain stem and spinal cord 
of the dimecron-treated rats (Table 3.26). 
Superoxide dismutase activity is universally present in 
respiring cells. The substrate is an unstable free radical 
that can be present only in minuscule amounts at any instant. 
It catalytically scavenges the superoxide radicals (Fridovich 
1972) , The SOD activity is said to be a natural defence 
mechanism against oxidative damage to the tissue (Fridovich 
1975). 
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Todate, no report is available on the effect of 
diniecron on the activity of SOD. However, dimecron has been 
reported to induce elevation of peroxidative degradation of 
brain lipids, i.e. lipid peroxidation (Naqvi et al 1988). The 
dipiecron-induced inhibition of SOD activity can, therefore be 
related to the enhanced lipid peroxidation in various CNS 
regions following dimecron toxicosis (Table 3.17), because 
SOD is known to protect against peroxidative damage. 
Dimecron has also been reported to enter the blood-brain 
barrier (Naqvi and Hasan 1990) and deplete -SH groups, 
another protective agents against peroxidative damage (Naqvi 
and Hasan 1991a). This is also in concordance with the 
diminution of SOD, reported here. 
Acetylhomocysteine thiolactone (cithiolone), however, 
revealed remarkable protective effect against inhibition of 
SOD (Fig. 3.8). Combined administration of cithiolone and 
diniecron showed significant protection of SOD activity (Table 
3.27), while the activity of SOD enhanced by cithiolone 
intoxication (Table 3.28). This protection might be the 
result of reactivation of SOD by cithiolone, through its 
antioxidative action, and hence enabling SOD to protect 
against dimecron-induced peroxidative damage. Interestingly, 
cithiolone has already be found to protect against dimecron-
induced enhanced lipid peroxidation in the CNS (Hasan et al 
1987), which also supports our findings. 
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4.8.0 Nucleic Acids 
The diniecron-intoxication was reported to induce 
significant perturbations in the levels of nucleic acids viz. 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in 
various regions of the CNS. 
4.8.1 Deoxyribonucleic Acid (DNA): 
Significant diminution was observed in the 
concentration of DNA in cerebrum, cerebellum, brain stem and 
spinal cord after toxicosis with dimecron (Table 3.29). One 
of the explanations for this depletion may be the 
degeneration of neurons and nerve fibres by the 
organophosphate toxicity, as suggested by Hasan et al (1979) . 
Our results agree with a number of previous studies 
regarding the effects of other organophosphate pesticides on 
the DNA contents of the brain. Phosalone has been reported to 
decrease DNA levels in various brain regions (Kirubagaran 
1984; Palanivelu 1984; Tamilvanan 1984). Decrement of DNA 
levels in various CNS regions following dichlorvos 
intoxication has also been reported (Paolo and Fini 1960) . 
Moreover, Dean (1972) observed diminution of the DNA 
concentration after dichlorvos toxicosis on cultured human 
lymphocytes. 
Different degrees of dimecron-induced depletion was 
noticed in different CNS regions. This shows different 
vulnerability of each region towards dimecron toxicosis. 
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Cerebelluir, showed highest DNA concentration as well as 
maximum dimecron-induced depletion, which is well in 
accordance with the findings of May and Grenell (1959) which 
indicate that cerebellum contains highest DNA content. This 
high leve] of DNA in cerebellum reflects the extreme cell 
density of cerebellar granular layer. 
Furthermore, the decrement of DNA contents reported in 
the present study can also be correlated with the findings 
of Tayyaba et a] (1981) revealing metasystox-induced 
diminution of DNA alongwith elevation of the activity of 
DNase, the principal enzyme involved in the degradation of 
DNA. 
The depletion of DNA contents in various CNS regions 
therefore, might be due to dimecron-induced perturbation in 
the metabolism of DNA, in addition to the degenerative 
changes . 
4.8.2. Ribonucleic Acid (RNA): 
In contrast, however, the response of RNA towards 
dimecron intoxication was entirely different from that of 
DNA. The RNA 3eve]s showed a significant increment in all 
the CNS regions following administration of dimecron (Table 
3.30) . 
This increase of RNA concentration may be explained on 
the basis of the suggestion of Heath (1961), that 
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3.31). This can be explained on the basis of the suggestion 
of Hyden and Lange (1972) that increased neuronal activity 
decreases or inhibits the protein synthesis. Also, Ahmad et 
al (1978) have observed higher utilization of protein due to 
increased proteolytic activity, which results in decrement of 
protein contents. 
Moreover, Bergen et al (1974) have correlated elevated 
RNA levels with increased nutrition or utilization of 
protein, which also supports the dimecron-induced depletion 
of protein (Table 3.31) . It has been observed that many 
environmental and nutritional factors may perturb the brain 
protein (Mcllwain and Bachelard 1971). Arnaiz et al (1975) 
are of the view that inhibition of protein level might be an 
indication of a disequilibrium in the normal energy-yielding 
metabolism. Free amino acids in the brain are known to be 
involved in a number of metabolic processes. Hence the 
increased demand for amino acids possibly may induce the 
break-down of proteins, as suggested by Neame (1968). 
The dimecron-induced reduction in the protein levels in 
all the CNS regions of rats, is in accordance with similar 
findings with other OP pesticides. Tayyaba et al (1981) 
observed depletion of proteins in the brain and spinal cord 
of the rats intoxicated with metasystox. Phosalone has been 
reported to diminish the protein levels in the CNS regions of 
rats (Kirubagaran 1984; PalaniveJu 1984; Tamilvanan 1984) and 
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demyelination, an important feature of organophosphate 
poisoning/ results in the increased production of FNA. 
Organophosphates have also been found to induce degenerative 
changes in neurons and nerve fibres (Hasan et al 1979). 
Interestingly, it has been demonstrated that the synthesis of 
RNA increases due to damage of neurons (Mcllwain and 
Bachelard 1971). 
Our results are also in agreement with previous studies 
revealing increased RNA concentration after toxicosis with 
other organophosphate pesticides (Kirubagaran 1984; 
Palanivelu 1984; Tamilvanan 1984). 
Bergen et a2 (1974) suggested that elevation of RNA 
levels may be associated with improvement of protein 
nutrition or tissue function which leads to decrement of 
protein. Interestingly, dimecron has also found to deplete 
the protein levels in the CNS (Table 3.31), which can be 
related to dimecron-induced increment of RNA (Table 3.30). 
Thus it can be concluded that the increase in the RNA 
concentration may be the result of possible selectively in 
protein synthesis (Prosser 1969), as well as diminished 
synthesis of RNA due to dimecron, poisoning. 
4.9.0. Protein: 
The total protein contents were reduced significantly 
in all the CNS regions of dimecron-intoxicated rats (Table 
183 
fish (Ravi 1984). Similar results were obtained in the CNS 
regions of fish brain following dichlorvos toxicosis (Rath 
and Misra 1980; Vadhva 1989). Methyl parathion has also 
been found to decrease the brain proteins (Khan 1989). 
It is likely that dirnecron inhibits the protein levels 
in the CNS probably by increasing the neuronal activity, and 
thereby enhancing the utilization of protein. 
4.10.0 Accumulation of Dirnecron in the CNSi 
The nervous system is one of the most susceptible and 
vulnerable organs of the body (WHO 1986). Affecting the 
nervous system is therefore the quickest and most certain way 
of chemically upsetting the body metabolism. The biological 
action of most of the organophosphate pesticides is 
attributed to attacking the neuronal system, probably by 
penetrating the blood-brain barrier, and henceforth 
inhibiting cholinesterases which leads to disruption of 
neuronal transmission system (Paul et al 1979; Hall and Kolbe 
1980). No report, however, is available till date, regarding 
accumulation of dimecron in the CNS following intoxication. 
The microanalysis of dimecron (Fig.3.9) accumulated in the 
CNS, is therefore of great importance for a better 
understanding of the OP neurotoxicity. 
The present investigation discloses a remarkable dose 
related accumulation of dimecron in the cerebrum, cerebellum, 
brain stem and spinal cord of dimecron-treated rats (Table 
184 
3.32). A distinct dose-dependent increment in the 
concentration of dimecron was noticed in all the investigated 
regions of the CNS (Naqvi and Hasan 1990a). 
Interestingly, in all the three dose groups (1.0, 1.5 
and 2.0 mg / kg b.wt.), gray matter-rich regions viz. 
cerebrum and cerebellum showed higher uptake of dimecron 
compared to white matter rich regions, brain stem and spinal 
cord. This difference may be explained by the fact that the 
blood flow in the gray matter is many times higher than in 
the white matter {Landau et al 1955). This suggests that the 
gray matter is likely to be affected more rapidly by a 
toxicant, as compared to the white matter (Naqvi and Hasan 
1990). 
Highest percent uptake of dimecron was observed in the 
cerebrum in all the dose groups (22.2, 22.3 and 24.2%, 
respectively), while the lowest was noticed in brain stem 
(11.7, 11.4 and 12.0%). Notably, this finding is well in 
concordance with our earlier study <Naqvi et al 1988) where 
cerebrum showed maximum dimecron-induced depletion of 
phospholipids (57%), while the minimum depletion (-29%) was 
discernible in the brain stem. This indicates that dimecron 
toxicosis influences cerebrum more severely compared to 
other regions. 
It can reasonably be concluded that dimecron penetrates 
the blood-brain barrier and exerts dose-dependent neurotoxic 
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effects through accumulation in the CNS, remarkably higher in 
the gray matter-rich regions than in the white matter-rich 
ones. 
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